{"recordsFiltered":48703,"recordsTotal":48703,"next":"http://staging-fdaaa.ebmdatalab.net/api/trials/?format=json&length=300&ordering=-sponsor__name&start=39300","previous":"http://staging-fdaaa.ebmdatalab.net/api/trials/?format=json&length=300&ordering=-sponsor__name&start=38700","results":[{"registry_id":"NCT01241864","publication_url":"https://clinicaltrials.gov/study/NCT01241864","title":"Islet Transplantation in Type 1 Diabetic Kidney Allograft","has_exemption":false,"start_date":"2010-12-31","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"University of Chicago","sponsor_slug":"university-of-chicago","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT01266096","publication_url":"https://clinicaltrials.gov/study/NCT01266096","title":"PET Imaging of Patients With Melanoma and Malignant Brain Tumors Using an 124I-labeled cRGDY Silica Nanomolecular Particle Tracer: A Microdosing Study","has_exemption":false,"start_date":"2011-01-31","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT01310530","publication_url":"https://clinicaltrials.gov/study/NCT01310530","title":"Phase 2 Trial of Partial Breast Proton Therapy for Early Stage Breast Cancer With Low and Intermediate Risk Factors.","has_exemption":false,"start_date":"2011-05-04","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Loma Linda University","sponsor_slug":"loma-linda-university","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT01386710","publication_url":"https://clinicaltrials.gov/study/NCT01386710","title":"Phase I/II Trial Of Repeated Super-selective Intraarterial Cerebral Infusion Of Bevacizumab Plus Carboplatin For Treatment Of Relapsed/Refractory Glioblastoma Multiforme And Anaplastic Astrocytoma","has_exemption":false,"start_date":"2011-09-30","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Northwell Health","sponsor_slug":"northwell-health","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT01453127","publication_url":"https://clinicaltrials.gov/study/NCT01453127","title":"DaTSCAN Imaging in Aging and Neurodegenerative Disease","has_exemption":false,"start_date":"2011-10-31","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02011971","publication_url":"https://clinicaltrials.gov/study/NCT02011971","title":"Cognitive Effects of Vinpocetine in Healthy Adults and Patients With Epilepsy","has_exemption":false,"start_date":"2012-02-29","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Stanford University","sponsor_slug":"stanford-university","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT01587352","publication_url":"https://clinicaltrials.gov/study/NCT01587352","title":"A Phase 2 Study of Vorinostat (NSC 701852) in Metastatic Uveal Melanoma","has_exemption":false,"start_date":"2012-05-29","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT00692939","publication_url":"https://clinicaltrials.gov/study/NCT00692939","title":"Autologous Stem Cell Transplantation With CD34-Selected Peripheral Blood Stem Cells (PBSC) in Pediatric and Adult Patients With Severe Crohn's Disease","has_exemption":false,"start_date":"2012-06-26","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Paul Szabolcs","sponsor_slug":"paul-szabolcs","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT00147056","publication_url":"https://clinicaltrials.gov/study/NCT00147056","title":"A Study to Evaluate the Safety and Feasibility of Transcranial MRI-Guided Focused Ultrasound Surgery in the Treatment of Brain Tumors","has_exemption":false,"start_date":"2012-08-31","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"InSightec","sponsor_slug":"insightec","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT01746849","publication_url":"https://clinicaltrials.gov/study/NCT01746849","title":"Phase II Study of Palifermin With Leuprolide Acetate or Degarelix For the Promotion of Immune Recovery Following Total Body Irradiation Based T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation","has_exemption":false,"start_date":"2012-12-31","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT01757626","publication_url":"https://clinicaltrials.gov/study/NCT01757626","title":"Phase I/II Study of Combination Therapy of Antibody Hu3F8 With Granulocyte- Macrophage Colony Stimulating Factor (GM-CSF) in Patients With Relapsed/Refractory High-Risk Neuroblastoma","has_exemption":false,"start_date":"2012-12-31","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT01851694","publication_url":"https://clinicaltrials.gov/study/NCT01851694","title":"Determination of Beta-cell Responsiveness to the Incretin Hormones GLP-1 and GIP in Cystic Fibrosis","has_exemption":false,"start_date":"2013-05-31","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"University of Pennsylvania","sponsor_slug":"university-of-pennsylvania","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT01918683","publication_url":"https://clinicaltrials.gov/study/NCT01918683","title":"A Pilot Trial of Transarterial Chemoembolization With or Without Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma Patients Awaiting Liver Transplantation","has_exemption":false,"start_date":"2013-07-31","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Abramson Cancer Center at Penn Medicine","sponsor_slug":"abramson-cancer-center-at-penn-medicine","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02202590","publication_url":"https://clinicaltrials.gov/study/NCT02202590","title":"Pilot Study to Image the Esophagus Using Spectrally Encoded Confocal Microscopy (SECM)","has_exemption":false,"start_date":"2013-10-31","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT01871766","publication_url":"https://clinicaltrials.gov/study/NCT01871766","title":"Risk-Adapted Focal Proton Beam Radiation and/or Surgery in Patients With Low, Intermediate and High Risk Rhabdomyosarcoma Receiving Standard or Intensified Chemotherapy","has_exemption":false,"start_date":"2013-12-04","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"St. Jude Children's Research Hospital","sponsor_slug":"st-jude-childrens-research-hospital","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT01863550","publication_url":"https://clinicaltrials.gov/study/NCT01863550","title":"Randomized Phase III Trial of Bortezomib, Lenalidomide, and Dexamethasone (VRd) Versus Carfilzomib, Lenalidomide, and Dexamethasone (CRd) Followed by Limited or Indefinite Duration Lenalidomide Maintenance in Patients With Newly Diagnosed Symptomatic Multiple Myeloma (ENDURANCE)","has_exemption":false,"start_date":"2013-12-06","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"ECOG-ACRIN Cancer Research Group","sponsor_slug":"ecog-acrin-cancer-research-group","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02020070","publication_url":"https://clinicaltrials.gov/study/NCT02020070","title":"A Phase 2 Study Combining Ipilimumab, Degarelix, and Radical Prostatectomy in Men With Newly Diagnosed Metastatic Castration Sensitive Prostate Cancer or Ipilimumab and Degarelix in Men With Biochemically Recurrent Castration Sensitive Prostate Cancer After Radical Prostatectomy","has_exemption":false,"start_date":"2013-12-18","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02969798","publication_url":"https://clinicaltrials.gov/study/NCT02969798","title":"Preservation of Beta Cell Function in Pre-diabetes in Subject With Impaired Fasting Glucose (IFG) and Impaired Glucose Tolerance (IGT)","has_exemption":false,"start_date":"2014-01-01","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"The University of Texas Health Science Center at San Antonio","sponsor_slug":"the-university-of-texas-health-science-center-at-san-antonio","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT01712620","publication_url":"https://clinicaltrials.gov/study/NCT01712620","title":"A Pilot Study of the Effect of Spironolactone Therapy on Exercise Capacity and Endothelial Dysfunction in Pulmonary Arterial Hypertension","has_exemption":false,"start_date":"2014-01-10","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"National Institutes of Health Clinical Center (CC)","sponsor_slug":"national-institutes-of-health-clinical-center-cc","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT01896999","publication_url":"https://clinicaltrials.gov/study/NCT01896999","title":"A Phase I Study With an Expansion Cohort/Randomized Phase II Study of the Combinations of Ipilimumab, Nivolumab and Brentuximab Vedotin in Patients With Relapsed/Refractory Hodgkin Lymphoma","has_exemption":false,"start_date":"2014-03-07","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02446405","publication_url":"https://clinicaltrials.gov/study/NCT02446405","title":"Randomised Phase 3 Trial of Enzalutamide in First Line Androgen Deprivation Therapy for Metastatic Prostate Cancer: ENZAMET","has_exemption":false,"start_date":"2014-03-31","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"University of Sydney","sponsor_slug":"university-of-sydney","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02143830","publication_url":"https://clinicaltrials.gov/study/NCT02143830","title":"A Phase II Trial of HSCT for the Treatment of Patients With Fanconi Anemia Lacking a Genotypically Identical Donor, Using a Risk-Adjusted Chemotherapy Only Cytoreduction With Busulfan, Cyclophosphamide and Fludarabine","has_exemption":false,"start_date":"2014-04-30","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Children's Hospital Medical Center, Cincinnati","sponsor_slug":"childrens-hospital-medical-center-cincinnati","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02087826","publication_url":"https://clinicaltrials.gov/study/NCT02087826","title":"Study of Clinical Response to Acute Metformin By Leveraging Evaluations During a Mixed Meal Tolerance Test for Exploring Glycemia and GeneticS (SCRAMBLED EGGS)","has_exemption":false,"start_date":"2014-04-30","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT00959140","publication_url":"https://clinicaltrials.gov/study/NCT00959140","title":"Phase II Study for Standardization of CD3+ T Cell Dose for Patients Receiving Allogeneic Peripheral Blood Stem Cell Transplants From Matched Related Donors","has_exemption":false,"start_date":"2014-10-31","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"University of Alabama at Birmingham","sponsor_slug":"university-of-alabama-at-birmingham","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02068586","publication_url":"https://clinicaltrials.gov/study/NCT02068586","title":"A Randomized Phase ll Study of Adjuvant Sunitinib or Valproic Acid in High-Risk Patients With Uveal Melanoma","has_exemption":false,"start_date":"2014-11-19","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University","sponsor_slug":"sidney-kimmel-comprehensive-cancer-center-at-thomas-jefferson-university","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02283996","publication_url":"https://clinicaltrials.gov/study/NCT02283996","title":"Adhesive Capsulitis: Prospective Analysis of Efficacy and Financial Impact for Use of Physical Therapy in Treatment","has_exemption":false,"start_date":"2014-11-30","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02227251","publication_url":"https://clinicaltrials.gov/study/NCT02227251","title":"A Phase 2b Open-label Study of Selinexor (KPT-330) in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)","has_exemption":false,"start_date":"2014-11-30","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Karyopharm Therapeutics Inc","sponsor_slug":"karyopharm-therapeutics-inc","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02286687","publication_url":"https://clinicaltrials.gov/study/NCT02286687","title":"Phase II Study of the PARP Inhibitor Talazoparib in Advanced Cancer Patients With Somatic Alterations in BRCA1/2, Mutations/Deletions in Other BRCA Pathway Genes and Germline Mutation in BRCA1/2 (Not Breast or Ovarian Cancer)","has_exemption":false,"start_date":"2014-12-22","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02312401","publication_url":"https://clinicaltrials.gov/study/NCT02312401","title":"Evaluation of Treatment Response Using Multiparametric MRI After Prostate Radiotherapy","has_exemption":false,"start_date":"2014-12-31","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02214836","publication_url":"https://clinicaltrials.gov/study/NCT02214836","title":"Ultrasound Imaging of Kidney Stones and Lithotripsy","has_exemption":false,"start_date":"2015-01-01","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"University of Washington","sponsor_slug":"university-of-washington","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02340117","publication_url":"https://clinicaltrials.gov/study/NCT02340117","title":"Phase II Study of Combined Targeted p53 Gene Therapy (SGT-53) Plus Gemcitabine/Nab-Paclitaxel for Treatment of Metastatic Pancreatic Cancer","has_exemption":false,"start_date":"2015-01-31","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"SynerGene Therapeutics, Inc.","sponsor_slug":"synergene-therapeutics-inc","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02912949","publication_url":"https://clinicaltrials.gov/study/NCT02912949","title":"A Phase I/II Study of MCLA-128, a Full Length IgG1 Bispecific Antibody Targeting HER2 and HER3, in Patients With Solid Tumors (eNRGy)","has_exemption":false,"start_date":"2015-01-31","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Partner Therapeutics, Inc.","sponsor_slug":"partner-therapeutics-inc","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02320435","publication_url":"https://clinicaltrials.gov/study/NCT02320435","title":"A Single-Arm Open-Label Multi-Centre Extension Study of Pertuzumab Administered As a Single Agent or in Combination With Other Anti-Cancer Therapies in Patients Previously Enrolled in a Hoffmann-La Roche-Sponsored Pertuzumab Study","has_exemption":false,"start_date":"2015-02-02","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Hoffmann-La Roche","sponsor_slug":"hoffmann-la-roche","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02381353","publication_url":"https://clinicaltrials.gov/study/NCT02381353","title":"Postoperative Pain Control After Enucleation or Evisceration, a Double-Masked Randomized Controlled Trial of Standard Versus Slow-release Bupivacaine","has_exemption":false,"start_date":"2015-02-28","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02387905","publication_url":"https://clinicaltrials.gov/study/NCT02387905","title":"Prophylactic Cement Augmentation for Patients at High Risk for Developing Vertebral Body Compression Fracture Following Spine Stereotactic Radiosurgery: A Randomized Phase II Clinical Trial","has_exemption":false,"start_date":"2015-03-09","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02503475","publication_url":"https://clinicaltrials.gov/study/NCT02503475","title":"Stanford Center for Back Pain","has_exemption":false,"start_date":"2015-03-31","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Stanford University","sponsor_slug":"stanford-university","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT05708898","publication_url":"https://clinicaltrials.gov/study/NCT05708898","title":"Effect of Pharyngeal Exerciser in Rehabilitation of Pharyngeal Phase of Swallowing in Patients With Dysphagia","has_exemption":false,"start_date":"2015-06-09","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Medical College of Wisconsin","sponsor_slug":"medical-college-of-wisconsin","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02465060","publication_url":"https://clinicaltrials.gov/study/NCT02465060","title":"Molecular Analysis for Therapy Choice (MATCH)","has_exemption":false,"start_date":"2015-08-17","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02532452","publication_url":"https://clinicaltrials.gov/study/NCT02532452","title":"Third Party Viral Specific T-cells (VSTs) for Treatment of Viral Infections in Immunocompromised Patients","has_exemption":false,"start_date":"2015-09-02","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Children's Hospital Medical Center, Cincinnati","sponsor_slug":"childrens-hospital-medical-center-cincinnati","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT03127631","publication_url":"https://clinicaltrials.gov/study/NCT03127631","title":"The Role of Androgen Deprivation Therapy In Cardiovascular Disease - A Longitudinal Prostate Cancer Study (RADICAL PC1) & A RAndomizeD Intervention for Cardiovascular and Lifestyle Risk Factors in Prostate Cancer Patients (RADICAL PC2)","has_exemption":false,"start_date":"2015-10-21","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"McMaster University","sponsor_slug":"mcmaster-university","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02600208","publication_url":"https://clinicaltrials.gov/study/NCT02600208","title":"BT13BTθ51 Unrelated and Partially Matched Related Donor Peripheral Stem Cell Transplantation With Alpha Beta T Cell and B Cell Depletion For Patients With Hematologic Malignancies","has_exemption":false,"start_date":"2015-10-31","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Julie-An M. Talano","sponsor_slug":"julie-an-m-talano","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT03307382","publication_url":"https://clinicaltrials.gov/study/NCT03307382","title":"Evaluation of the Utility of Single-operator Digital Cholangioscopy During Endoscopic Retrograde Cholangiopancreatography in the Diagnosis of Malignant and Benign Biliary Strictures","has_exemption":false,"start_date":"2015-12-15","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Chinese University of Hong Kong","sponsor_slug":"chinese-university-of-hong-kong","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02718833","publication_url":"https://clinicaltrials.gov/study/NCT02718833","title":"A Phase II Study of Elotuzumab in Combination With Pomalidomide, Bortezomib, and Dexamethasone in Relapsed and Refractory Multiple Myeloma","has_exemption":false,"start_date":"2016-06-21","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02861898","publication_url":"https://clinicaltrials.gov/study/NCT02861898","title":"Phase I/II Trial of Super-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed Glioblastoma","has_exemption":false,"start_date":"2016-06-30","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Northwell Health","sponsor_slug":"northwell-health","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02744677","publication_url":"https://clinicaltrials.gov/study/NCT02744677","title":"COngenital Multicenter Trial of Pulmonic vAlve Dysfunction Studying the SAPIEN 3 interventIONal THV","has_exemption":false,"start_date":"2016-07-05","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Edwards Lifesciences","sponsor_slug":"edwards-lifesciences","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02595944","publication_url":"https://clinicaltrials.gov/study/NCT02595944","title":"Adjuvant Nivolumab in Resected Lung Cancers (ANVIL)-A Randomized Phase III Study of Nivolumab After Surgical Resection and Adjuvant Chemotherapy in Non-Small Cell Lung Cancers","has_exemption":false,"start_date":"2016-07-22","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02584244","publication_url":"https://clinicaltrials.gov/study/NCT02584244","title":"Feasibility of the LUM Imaging System for Detection of Gastrointestinal Cancers","has_exemption":false,"start_date":"2016-08-04","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Lumicell, Inc.","sponsor_slug":"lumicell-inc","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02754752","publication_url":"https://clinicaltrials.gov/study/NCT02754752","title":"Randomized-Controlled Trial of Acupuncture for Chronic Pain After Breast Cancer Treatment","has_exemption":false,"start_date":"2016-09-13","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02886585","publication_url":"https://clinicaltrials.gov/study/NCT02886585","title":"Phase II Trial of Pembrolizumab in Central Nervous System Metastases From Multiple Histologies","has_exemption":false,"start_date":"2016-10-31","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02935361","publication_url":"https://clinicaltrials.gov/study/NCT02935361","title":"A Phase I/II Multicenter Study Combining Guadecitabine, a DNA Methyltransferase Inhibitor, With Atezolizumab, an Immune Checkpoint Inhibitor, in Patients With Intermediate or High-Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia","has_exemption":false,"start_date":"2016-11-02","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"University of Southern California","sponsor_slug":"university-of-southern-california","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02989584","publication_url":"https://clinicaltrials.gov/study/NCT02989584","title":"A Pilot Safety Study and Single Arm Phase II Study of Gemcitabine and Cisplatin With Atezolizumab (MPDL3280A) in Patients With Metastatic and Muscle Invasive Bladder Cancer, Respectively","has_exemption":false,"start_date":"2016-12-20","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT03028246","publication_url":"https://clinicaltrials.gov/study/NCT03028246","title":"A Feasibility Safety Study Using the ExAblate 4000 System in the Management of Benign Centrally-Located Intracranial Tumors Which Require Clinical Intervention in Pediatric and Young Adult Subjects","has_exemption":false,"start_date":"2017-02-28","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"InSightec","sponsor_slug":"insightec","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04204837","publication_url":"https://clinicaltrials.gov/study/NCT04204837","title":"Phase II Study of Nivolumab (Group 1) and Nivolumab Plus Relatlimab (Group 2) in Patients With Locally Advanced/ Metastatic Squamous Cell Carcinoma of the Skin","has_exemption":false,"start_date":"2017-03-06","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Salzburger Landeskliniken","sponsor_slug":"salzburger-landeskliniken","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT02920788","publication_url":"https://clinicaltrials.gov/study/NCT02920788","title":"Multi-Level Assessment and Rehabilitation of Combat Mild TBI","has_exemption":false,"start_date":"2017-03-09","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"VA Office of Research and Development","sponsor_slug":"va-office-of-research-and-development","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03093961","publication_url":"https://clinicaltrials.gov/study/NCT03093961","title":"A Study to Evaluate the Corvia Medical, Inc. IASD® System II to REDUCE Elevated Left Atrial Pressure in Patients With Heart Failure With Reduced Ejection Fraction","has_exemption":false,"start_date":"2017-03-10","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Corvia Medical","sponsor_slug":"corvia-medical","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06385496","publication_url":"https://clinicaltrials.gov/study/NCT06385496","title":"MATCH Treatment Subprotocol L: Phase II Study of MLN0128 (TAK-228) in Patients With Tumors Wtih mTOR Mutations","has_exemption":false,"start_date":"2017-03-12","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06390852","publication_url":"https://clinicaltrials.gov/study/NCT06390852","title":"MATCH Treatment Subprotocol Z1E: Larotrectinib (LOXO-101) in Patients With Tumors With NTRK Fusions","has_exemption":false,"start_date":"2017-03-12","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06390865","publication_url":"https://clinicaltrials.gov/study/NCT06390865","title":"MATCH Treatment Subprotocol M: Phase II Study of MLN0128 (Tak-228) in Patients With Tumors With TSC1 or TSC2 Mutations","has_exemption":false,"start_date":"2017-03-12","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT02344355","publication_url":"https://clinicaltrials.gov/study/NCT02344355","title":"Pharmacological Ascorbate Combined With Radiation and Temozolomide in Glioblastoma Multiforme: A Phase 2 Trial","has_exemption":false,"start_date":"2017-03-13","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Bryan Allen","sponsor_slug":"bryan-allen","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04439227","publication_url":"https://clinicaltrials.gov/study/NCT04439227","title":"MATCH Treatment Subprotocol Z1I: Phase II Study of AZD1775 in Patients With Tumors Containing BRCA1 and BRCA2 Mutations","has_exemption":false,"start_date":"2017-03-13","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03096093","publication_url":"https://clinicaltrials.gov/study/NCT03096093","title":"A Phase I Clinical Study to Determine the Optimal Dose for the Safe Immune Restoration and Immune Response of Allogeneic Cell Immunotherapy (ACIT-1) in Adult Cancer Patients","has_exemption":false,"start_date":"2017-04-25","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Cancer Vaccines Limited","sponsor_slug":"cancer-vaccines-limited","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03099356","publication_url":"https://clinicaltrials.gov/study/NCT03099356","title":"An Open Label Phase II Trial Evaluating the Efficacy of Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer","has_exemption":false,"start_date":"2017-04-27","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"University of Michigan Rogel Cancer Center","sponsor_slug":"university-of-michigan-rogel-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03639701","publication_url":"https://clinicaltrials.gov/study/NCT03639701","title":"Deoxythymidine and Deoxycytidine Treatment for Thymidine Kinase 2 (TK2) Deficiency","has_exemption":false,"start_date":"2017-05-16","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Columbia University","sponsor_slug":"columbia-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT02981628","publication_url":"https://clinicaltrials.gov/study/NCT02981628","title":"A Phase 2 Study of Inotuzumab Ozogamicin (NSC# 772518) in Children and Young Adults With Relapsed or Refractory CD22+ B-Acute Lymphoblastic Leukemia (B-ALL)","has_exemption":false,"start_date":"2017-06-19","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Children's Oncology Group","sponsor_slug":"childrens-oncology-group","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT02675959","publication_url":"https://clinicaltrials.gov/study/NCT02675959","title":"Safety and Efficacy of Prophylactic Defibrotide in Children, Adolescents, and Young Adults With Sickle Cell Disease or Beta Thalassemia Following MAC and Haploidentical Stem Cell Transplantation Utilizing CD34 Enrichment and T-Cell (CD3) Addback","has_exemption":false,"start_date":"2017-07-01","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"New York Medical College","sponsor_slug":"new-york-medical-college","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03223922","publication_url":"https://clinicaltrials.gov/study/NCT03223922","title":"Preservation of Cognition and Neuropsychiatric Functioning With Corpus Callosum Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases: A Pilot Study","has_exemption":false,"start_date":"2017-07-19","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","sponsor_slug":"sidney-kimmel-comprehensive-cancer-center-at-johns-hopkins","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03127774","publication_url":"https://clinicaltrials.gov/study/NCT03127774","title":"Phase II Trial of Surgical Resection and Heated Intraperitoneal Peritoneal Chemotherapy (HIPEC) for Adrenocortical Carcinoma","has_exemption":false,"start_date":"2017-09-22","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Columbia University","sponsor_slug":"columbia-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT02935478","publication_url":"https://clinicaltrials.gov/study/NCT02935478","title":"A Single Center, Non-randomized Study to Evaluate the Safety and Efficacy of Left Gastric Artery Embolization in Obese Patients With Hepatocellular Carcinoma to Achieve Appropriate Weight Loss That May Allow Them to be Transplanted","has_exemption":false,"start_date":"2017-10-18","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"St. Louis University","sponsor_slug":"st-louis-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03286530","publication_url":"https://clinicaltrials.gov/study/NCT03286530","title":"Phase II Study of Maintenance Ruxolitinib After Allogeneic Stem Cell Transplantation for Older Patients With Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS) in Complete Remission","has_exemption":false,"start_date":"2017-11-03","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03339128","publication_url":"https://clinicaltrials.gov/study/NCT03339128","title":"A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study to Evaluate the Safety and Efficacy of Eluxadoline in Pediatric Participants (Age 6 to 17 Years) With Irritable Bowel Syndrome With Diarrhea (IBS-D)","has_exemption":false,"start_date":"2017-11-15","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"AbbVie","sponsor_slug":"abbvie","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03317158","publication_url":"https://clinicaltrials.gov/study/NCT03317158","title":"PhAse 1/2 StuDy of Modern ImmunotherApy in BCG-Unresponsive, BCG-RelaPsing, and High-Risk BCG-Naive Non-muscle Invasive UroThelial Carcinoma of the BLADDER","has_exemption":false,"start_date":"2017-11-21","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Noah Hahn, M.D.","sponsor_slug":"noah-hahn-md","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT02901184","publication_url":"https://clinicaltrials.gov/study/NCT02901184","title":"Spironolactone Initiation Registry Randomized Interventional Trial in Heart Failure With Preserved Ejection Fraction, SPIRRIT-HFPEF","has_exemption":false,"start_date":"2017-11-23","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Uppsala University","sponsor_slug":"uppsala-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03377387","publication_url":"https://clinicaltrials.gov/study/NCT03377387","title":"Phase Ib/II Study of Capecitabine 7/7 Schedule With Neratinib in Patients With Metastatic HER2-Positive Breast Cancer","has_exemption":false,"start_date":"2017-12-13","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03142152","publication_url":"https://clinicaltrials.gov/study/NCT03142152","title":"Assessment of the Carillon Mitral Contour System® in Treating Heart Failure With Functional Mitral Regurgitation","has_exemption":false,"start_date":"2018-01-01","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Cardiac Dimensions, Inc.","sponsor_slug":"cardiac-dimensions-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03224000","publication_url":"https://clinicaltrials.gov/study/NCT03224000","title":"Bayesian Phase II Trial of Magnetic Resonance Imaging Guided Radiotherapy Dose Adaptation in Human Papilloma Virus Positive Oropharyngeal Cancer","has_exemption":false,"start_date":"2018-01-17","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03982160","publication_url":"https://clinicaltrials.gov/study/NCT03982160","title":"Role of Decreased Nitric Oxide in the Tonic Elevation of Resting Sympathetic Nerve Activity in Chronic Kidney Disease Patients","has_exemption":false,"start_date":"2018-02-01","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"The University of Texas at Arlington","sponsor_slug":"the-university-of-texas-at-arlington","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03161522","publication_url":"https://clinicaltrials.gov/study/NCT03161522","title":"A Randomized Trial Comparing Early Local Chemoradiation Therapy +/- Surgery Versus Systemic Therapy for Patients With Esophageal or Gastric Cancer With Oligometastases","has_exemption":false,"start_date":"2018-02-19","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03603405","publication_url":"https://clinicaltrials.gov/study/NCT03603405","title":"Phase I-II Study Evaluating HSV-tK + VALACYCLOVIR GENE THERAPY Combination With Radiotherapy and Chemotherapy for Newly Diagnosed Anaplastic Astrocytoma and Glioblastoma Multiforme.","has_exemption":false,"start_date":"2018-02-28","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"The Methodist Hospital Research Institute","sponsor_slug":"the-methodist-hospital-research-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03431090","publication_url":"https://clinicaltrials.gov/study/NCT03431090","title":"HAPLEUK17, Haploidentical Hematopoietic Cell Transplantation for Children With Hematologic Malignancies and Myelodysplasia","has_exemption":false,"start_date":"2018-03-02","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Nationwide Children's Hospital","sponsor_slug":"nationwide-childrens-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03383094","publication_url":"https://clinicaltrials.gov/study/NCT03383094","title":"Phase II Randomized Trial of Radiotherapy With Concurrent and Adjuvant Pembrolizumab (Keytruda®) Versus Concurrent Chemotherapy in Patients With Advanced/Intermediate-Risk p16+ Head and Neck Squamous Cell Carcinoma (KEYCHAIN)","has_exemption":false,"start_date":"2018-03-15","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Loren Mell, MD","sponsor_slug":"loren-mell-md","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03420482","publication_url":"https://clinicaltrials.gov/study/NCT03420482","title":"Fecal Microbiota Transplant as Treatment of Hepatic Encephalopathy","has_exemption":false,"start_date":"2018-04-01","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03519451","publication_url":"https://clinicaltrials.gov/study/NCT03519451","title":"Use of a Smartphone Mobile Application (App) to Enhance Smoking Cessation Treatment - A Pilot Study","has_exemption":false,"start_date":"2018-04-25","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03467867","publication_url":"https://clinicaltrials.gov/study/NCT03467867","title":"A Phase II Study of Venetoclax and Rituximab/Hyaluronidase Human in Relapsed/Refractory CLL","has_exemption":false,"start_date":"2018-04-26","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Georgetown University","sponsor_slug":"georgetown-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03604198","publication_url":"https://clinicaltrials.gov/study/NCT03604198","title":"An Open-Label Extension Study of the Safety of Relacorilant (CORT125134) in the Treatment of the Signs and Symptoms of Endogenous Cushing Syndrome","has_exemption":false,"start_date":"2018-05-07","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Corcept Therapeutics","sponsor_slug":"corcept-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03473249","publication_url":"https://clinicaltrials.gov/study/NCT03473249","title":"Clinical Effectiveness of Contrast-Enhanced Ultrasound in the Evaluation of Blunt Abdominal Trauma in Young Children","has_exemption":false,"start_date":"2018-05-09","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Children's Hospital of Philadelphia","sponsor_slug":"childrens-hospital-of-philadelphia","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03533582","publication_url":"https://clinicaltrials.gov/study/NCT03533582","title":"Pediatric Hepatic Malignancy International Therapeutic Trial (PHITT)","has_exemption":false,"start_date":"2018-05-24","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Children's Oncology Group","sponsor_slug":"childrens-oncology-group","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03491683","publication_url":"https://clinicaltrials.gov/study/NCT03491683","title":"An Open-Label, Multi-Center Trial of INO-5401 and INO-9012 Delivered by Electroporation (EP) in Combination With REGN2810 in Subjects With Newly-Diagnosed Glioblastoma (GBM)","has_exemption":false,"start_date":"2018-05-31","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Inovio Pharmaceuticals","sponsor_slug":"inovio-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03490929","publication_url":"https://clinicaltrials.gov/study/NCT03490929","title":"Contrast Enhanced Ultrasonography for Blunt Abdominal Trauma Imaging in Children","has_exemption":false,"start_date":"2018-06-01","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Children's Hospital of Philadelphia","sponsor_slug":"childrens-hospital-of-philadelphia","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03230565","publication_url":"https://clinicaltrials.gov/study/NCT03230565","title":"A Prospective Comparison of Pain and Analgesia in Patients With Continuous Peripheral Nerve Block Catheters Using Continuous Infusion or Scheduled Bolus Infusion","has_exemption":false,"start_date":"2018-06-01","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Stanford University","sponsor_slug":"stanford-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03626038","publication_url":"https://clinicaltrials.gov/study/NCT03626038","title":"A.L.P.S. Proximal Humerus Plating System Post-Market Clinical Follow-up Study","has_exemption":false,"start_date":"2018-06-19","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Zimmer Biomet","sponsor_slug":"zimmer-biomet","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03382457","publication_url":"https://clinicaltrials.gov/study/NCT03382457","title":"Clinical Study of Edwards Cardioband FIT Valve Repair System","has_exemption":false,"start_date":"2018-07-01","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Edwards Lifesciences","sponsor_slug":"edwards-lifesciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03301038","publication_url":"https://clinicaltrials.gov/study/NCT03301038","title":"Rifampin to Reduce Elevated Levels of Blood and Urine Calcium in Patients With Inactivating Mutations in the CYP24A1 Gene","has_exemption":false,"start_date":"2018-07-25","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Children's Hospital of Philadelphia","sponsor_slug":"childrens-hospital-of-philadelphia","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03525873","publication_url":"https://clinicaltrials.gov/study/NCT03525873","title":"A Study of Cancer Related Fatigue in Patients With Metastatic Cancer Receiving Anti-PD1 Immunotherapy","has_exemption":false,"start_date":"2018-08-02","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03487185","publication_url":"https://clinicaltrials.gov/study/NCT03487185","title":"A Randomized Trial of Continuous Positive Airway Pressure (CPAP) for Sleep Apnea in Pregnancy","has_exemption":false,"start_date":"2018-08-03","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"The George Washington University Biostatistics Center","sponsor_slug":"the-george-washington-university-biostatistics-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03603912","publication_url":"https://clinicaltrials.gov/study/NCT03603912","title":"Upstream Targeting for the Prevention of Atrial Fibrillation: Targeting Risk Interventions and Metformin for Atrial Fibrillation (TRIM-AF)","has_exemption":false,"start_date":"2018-08-24","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Mina Chung, MD","sponsor_slug":"mina-chung-md","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03394066","publication_url":"https://clinicaltrials.gov/study/NCT03394066","title":"Understanding the Acute Modulation of Brain Activity by Transcranial Magnetic Stimulation","has_exemption":false,"start_date":"2018-09-19","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"National Institute on Drug Abuse (NIDA)","sponsor_slug":"national-institute-on-drug-abuse-nida","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03412760","publication_url":"https://clinicaltrials.gov/study/NCT03412760","title":"Hydrops: Diagnosing & Redefining Outcomes With Precision Study","has_exemption":false,"start_date":"2018-10-11","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"University of California, San Francisco","sponsor_slug":"university-of-california-san-francisco","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03629171","publication_url":"https://clinicaltrials.gov/study/NCT03629171","title":"Phase II Study of CPX-351 in Combination With Venetoclax in Patients With Acute Myeloid Leukemia (AML)","has_exemption":false,"start_date":"2018-10-29","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03266627","publication_url":"https://clinicaltrials.gov/study/NCT03266627","title":"A Pilot Study in the Treatment of Refractory Adenovirus (ADV) Infection With Related Donor ADV Cytotoxic T-Lymphocytes (ADV-CTLs)in Children, Adolescents and Young Adult Recipients","has_exemption":false,"start_date":"2018-11-01","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"New York Medical College","sponsor_slug":"new-york-medical-college","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03266640","publication_url":"https://clinicaltrials.gov/study/NCT03266640","title":"A Pilot Study in the Treatment of Refractory Cytomegalovirus (CMV) Infections With Related Donor CMV Specific Cytotoxic T-cells (CTLs) in Children, Adolescents and Young Adult Recipients","has_exemption":false,"start_date":"2018-11-01","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"New York Medical College","sponsor_slug":"new-york-medical-college","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06254794","publication_url":"https://clinicaltrials.gov/study/NCT06254794","title":"Effect of Blood Flow Restriction (BFR) Rehabilitation After Achilles Tendon Rupture Reconstruction","has_exemption":false,"start_date":"2018-11-13","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"The Methodist Hospital Research Institute","sponsor_slug":"the-methodist-hospital-research-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03712605","publication_url":"https://clinicaltrials.gov/study/NCT03712605","title":"STAMP: Surgically Treated Adjuvant Merkel Cell Carcinoma With Pembrolizumab, a Phase III Trial","has_exemption":false,"start_date":"2018-11-15","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03747146","publication_url":"https://clinicaltrials.gov/study/NCT03747146","title":"Expanding the Peri-operative Surgical Home Model: ERAS TKR With a Transitional Pain Service (TeleTPS)- Continuous Adductor Canal Catheter Versus Adductor Canal Block for Total Knee Arthroplasty, a Randomized Double-blind Controlled Trial","has_exemption":false,"start_date":"2018-11-16","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Hospital for Special Surgery, New York","sponsor_slug":"hospital-for-special-surgery-new-york","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03637816","publication_url":"https://clinicaltrials.gov/study/NCT03637816","title":"Qualitative Study on Experiences Related to Anorexia and the Effects of Anamorelin and Placebo in Advanced Non-Small-Cell Lung Cancer Patients With Anorexia-Cachexia: A Preliminary Study","has_exemption":false,"start_date":"2018-11-27","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03737955","publication_url":"https://clinicaltrials.gov/study/NCT03737955","title":"A Phase 2 Trial of Fractionated Gemtuzumab Ozogamicin to Eradicate Measurable Residual Disease in Acute Myeloid Leukemia Patients (GO for MRD)","has_exemption":true,"start_date":"2018-11-30","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"University of Washington","sponsor_slug":"university-of-washington","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03579316","publication_url":"https://clinicaltrials.gov/study/NCT03579316","title":"EFFORT: Efficacy of AZD1775 in Parp Resistance; A Randomized 2-Arm, Non-Comparative Phase 2 Study of AZD1775 Alone or AZD1775 and Olaparib in Women With Ovarian Cancer Who Have Progressed During PARP Inhibition","has_exemption":false,"start_date":"2018-12-07","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03349528","publication_url":"https://clinicaltrials.gov/study/NCT03349528","title":"A Double-Blind Placebo-Controlled Trial of a Probiotic Supplement to Prevent Relapse and Improve the Clinical Course After Hospitalization for Bipolar Depression","has_exemption":false,"start_date":"2018-12-11","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Sheppard Pratt Health System","sponsor_slug":"sheppard-pratt-health-system","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03694756","publication_url":"https://clinicaltrials.gov/study/NCT03694756","title":"TMEM-MRI: A Pilot Feasibility Study of Magnetic Resonance Imaging for Imaging of TMEM (Tumor Microenvironment of Metastasis) in Patients With Operable Breast Cancer","has_exemption":false,"start_date":"2018-12-12","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Montefiore Medical Center","sponsor_slug":"montefiore-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03793140","publication_url":"https://clinicaltrials.gov/study/NCT03793140","title":"A Phase II Clinical Trial of CPI-613 in Patients With Relapsed or Refractory Burkitt Lymphoma/Leukemia or High-grade B-cell Lymphoma With Rearrangements of MYC and BCL2 and/or BCL6","has_exemption":false,"start_date":"2018-12-31","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03652753","publication_url":"https://clinicaltrials.gov/study/NCT03652753","title":"Prevention of Cartilage Cell Death Following a Pilon Fracture With Intra-articular Injection of N-Acetylcysteine (Pilon NAC)","has_exemption":false,"start_date":"2019-01-01","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"University of Missouri-Columbia","sponsor_slug":"university-of-missouri-columbia","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03587701","publication_url":"https://clinicaltrials.gov/study/NCT03587701","title":"A Phase II Placebo Controlled Study of the Effects of Anakinra (Kineret) in Subjects With Corticosteroid-Resistant/Intolerant Meniere's Disease (CR-MD) and Corticosteroid-Resistant/Intolerant Autoimmune Inner Ear Disease Disease (CR-AIED)","has_exemption":false,"start_date":"2019-01-03","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Northwell Health","sponsor_slug":"northwell-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03593759","publication_url":"https://clinicaltrials.gov/study/NCT03593759","title":"Cardiac Sarcoidosis Multi-Center Randomized Controlled Trial","has_exemption":false,"start_date":"2019-01-15","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Ottawa Heart Institute Research Corporation","sponsor_slug":"ottawa-heart-institute-research-corporation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03785249","publication_url":"https://clinicaltrials.gov/study/NCT03785249","title":"A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients With Advanced Solid Tumors With KRAS G12C Mutation KRYSTAL-1","has_exemption":false,"start_date":"2019-01-15","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Mirati Therapeutics Inc.","sponsor_slug":"mirati-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03519464","publication_url":"https://clinicaltrials.gov/study/NCT03519464","title":"A Phase 2, Open-Label Study to Assess the Immunogenicity of the 9-Valent Human Papillomavirus Recombinant Vaccine in Patients With Idiopathic CD4 T Cell Lymphocytopenia","has_exemption":false,"start_date":"2019-02-04","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","sponsor_slug":"national-institute-of-allergy-and-infectious-diseases-niaid","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03778060","publication_url":"https://clinicaltrials.gov/study/NCT03778060","title":"Cala TWO Device: Clinical Efficacy and Effects on Regional Brain Metabolism in Essential Tremor Subjects Scheduled to Undergo Deep Brain Stimulation Surgery","has_exemption":false,"start_date":"2019-02-11","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03784326","publication_url":"https://clinicaltrials.gov/study/NCT03784326","title":"Phase I/II Study of Perioperative Chemotherapy Plus Immunotherapy Followed by Surgery in Localized Esophageal and Gastroesophageal Adenocarcinoma","has_exemption":false,"start_date":"2019-02-19","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03823534","publication_url":"https://clinicaltrials.gov/study/NCT03823534","title":"Post-Op Pain Control for Prophylactic Intramedullary Nailing.","has_exemption":false,"start_date":"2019-02-20","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"St. Louis University","sponsor_slug":"st-louis-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03769298","publication_url":"https://clinicaltrials.gov/study/NCT03769298","title":"Conversion From Immediate Release Tacrolimus to Envarsus XR® in Simultaneous Pancreas-Kidney Recipients: Assessment of Functional, Safety and Quality of Life Outcomes (CIRTEN SPK)","has_exemption":false,"start_date":"2019-02-27","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"University of Wisconsin, Madison","sponsor_slug":"university-of-wisconsin-madison","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03610711","publication_url":"https://clinicaltrials.gov/study/NCT03610711","title":"REACTION (Radiation Enhanced Assessment of Combination Therapies in Immuno-ONcology) - Nivolumab or Nivolumab in Combination With Other Immuno-oncology (IO) Agents After Targeted Systemic Radiation in Patients With Advanced Esophagogastric Cancer","has_exemption":false,"start_date":"2019-03-06","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","sponsor_slug":"sidney-kimmel-comprehensive-cancer-center-at-johns-hopkins","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03290534","publication_url":"https://clinicaltrials.gov/study/NCT03290534","title":"Feasibility Study to Treat Lung Cancer With the Permanently Implantable LDR CivaSheet®","has_exemption":false,"start_date":"2019-03-13","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"CivaTech Oncology","sponsor_slug":"civatech-oncology","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03856632","publication_url":"https://clinicaltrials.gov/study/NCT03856632","title":"Novel Medical Adjunctive Therapy to Catheter Ablation For Atrial Fibrillation (AF)","has_exemption":false,"start_date":"2019-03-18","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"University of Miami","sponsor_slug":"university-of-miami","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03719430","publication_url":"https://clinicaltrials.gov/study/NCT03719430","title":"A Phase II Trial Evaluating APX005M (a CD40 Agonistic Monoclonal Antibody) in Combination With Standard-of-Care Doxorubicin for the Treatment of Advanced Sarcomas","has_exemption":false,"start_date":"2019-03-20","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Alexander Z. Wei, MD","sponsor_slug":"alexander-z-wei-md","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03909282","publication_url":"https://clinicaltrials.gov/study/NCT03909282","title":"A Randomized Phase II Study Comparing Surgical Excision Versus Neoadjuvant Radiotherapy Followed by Delayed Surgical Excision of Ductal Carcinoma In Situ (NORDIS)","has_exemption":false,"start_date":"2019-03-22","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Stanford University","sponsor_slug":"stanford-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03513562","publication_url":"https://clinicaltrials.gov/study/NCT03513562","title":"Phase 2 Study of Venetoclax Added to Ibrutinib to Eliminate Ibrutinib Resistance Mutations in CLL","has_exemption":false,"start_date":"2019-03-26","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Ohio State University Comprehensive Cancer Center","sponsor_slug":"ohio-state-university-comprehensive-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03685890","publication_url":"https://clinicaltrials.gov/study/NCT03685890","title":"A Phase Ib/II Randomized Double-blind Placebo Controlled Trial Evaluating the Effect of Nivolumab for Patients With In-transit Melanoma Metastases Treated With Isolated Limb Perfusion - the NivoILP Trial","has_exemption":false,"start_date":"2019-04-01","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Vastra Gotaland Region","sponsor_slug":"vastra-gotaland-region","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03652428","publication_url":"https://clinicaltrials.gov/study/NCT03652428","title":"Phase I Study of Concurrent Nab-Paclitaxel + Gemcitabine With Hypofractionated, Ablative Proton Therapy for Locally Advanced Pancreatic Cancer","has_exemption":false,"start_date":"2019-04-02","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"University of Maryland, Baltimore","sponsor_slug":"university-of-maryland-baltimore","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03808610","publication_url":"https://clinicaltrials.gov/study/NCT03808610","title":"Phase I/II Study of the Combination of Low-Intensity Chemotherapy and Venetoclax (ABT-199) in Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL)","has_exemption":false,"start_date":"2019-04-03","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03519269","publication_url":"https://clinicaltrials.gov/study/NCT03519269","title":"Conventional vs. Robotic-Assisted Total Knee Arthroplasty: A Prospective, Randomized Trial of Clinical, Functional, and Radiographic Outcomes","has_exemption":false,"start_date":"2019-04-17","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Columbia University","sponsor_slug":"columbia-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03948867","publication_url":"https://clinicaltrials.gov/study/NCT03948867","title":"Stroke Prevention With Hydroxyurea Enabled Through Research and Education (SPHERE): A Prospective Trial to Reduce Primary Stroke in Children With Sickle Cell Anaemia","has_exemption":false,"start_date":"2019-04-24","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Children's Hospital Medical Center, Cincinnati","sponsor_slug":"childrens-hospital-medical-center-cincinnati","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05589753","publication_url":"https://clinicaltrials.gov/study/NCT05589753","title":"Targeting Chemoreceptor Control of Breathing During Sleep to Mitigate Opioid-Associated Sleep Disordered Breathing","has_exemption":false,"start_date":"2019-05-02","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"VA Office of Research and Development","sponsor_slug":"va-office-of-research-and-development","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03604991","publication_url":"https://clinicaltrials.gov/study/NCT03604991","title":"A Phase II/III Study of Peri-Operative Nivolumab and Ipilimumab in Patients With Locoregional Esophageal and Gastroesophageal Junction Adenocarcinoma","has_exemption":false,"start_date":"2019-05-03","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06541015","publication_url":"https://clinicaltrials.gov/study/NCT06541015","title":"TENS (Transcutaneous Electrical Nerve Stimulation): Effect of Transcutaneous Spinal Direct Current Stimulation on Lower Limb Reflex, Volitional, and Functional Movement Post-stroke","has_exemption":false,"start_date":"2019-06-21","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"University of Texas Southwestern Medical Center","sponsor_slug":"university-of-texas-southwestern-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03054831","publication_url":"https://clinicaltrials.gov/study/NCT03054831","title":"The Effect of General Anesthesia on Pharmacokinetics and Pharmacogenomics of Liquid Oxycodone in Pediatric Surgical Patients","has_exemption":false,"start_date":"2019-07-08","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Boston Children’s Hospital","sponsor_slug":"boston-childrens-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06400225","publication_url":"https://clinicaltrials.gov/study/NCT06400225","title":"MATCH Treatment Subprotocol Z1L: BVD-523FB (Ulixertinib) in Patients With Tumors With BRAF Fusions, or With Non-V600E, Non-V600K BRAF Mutations","has_exemption":false,"start_date":"2019-07-24","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03909334","publication_url":"https://clinicaltrials.gov/study/NCT03909334","title":"An Open-Label Randomized Phase II Study of Combining Osimertinib With and Without Ramucirumab in Tyrosine Kinase Inhibitor (TKI)-naïve Epidermal Growth Factor Receptor (EGFR)-Mutant Locally Advanced or Metastatic NSCLC","has_exemption":false,"start_date":"2019-07-25","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Xiuning Le","sponsor_slug":"xiuning-le","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04039750","publication_url":"https://clinicaltrials.gov/study/NCT04039750","title":"Use of Antibiotic Irrigation to Decrease Wound Infections in Pediatric Perforated Appendicitis","has_exemption":false,"start_date":"2019-07-25","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Prisma Health-Upstate","sponsor_slug":"prisma-health-upstate","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03789552","publication_url":"https://clinicaltrials.gov/study/NCT03789552","title":"A Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group Phase 3 Study to Confirm the Safety and Efficacy of T89 in Patients With Stable Angina Pectoris, With an Extended Open-label Period to Evaluate the Long-term Safety","has_exemption":false,"start_date":"2019-08-01","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Tasly Pharmaceuticals, Inc.","sponsor_slug":"tasly-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06554158","publication_url":"https://clinicaltrials.gov/study/NCT06554158","title":"A Phase II Study of Post-Resection Radiation Dose and Treatment Site De-Escalation for Favorable Prognosis Human Papilloma Virus (HPV) or p16-Positive Oropharyngeal Cancer","has_exemption":false,"start_date":"2019-08-01","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Georgetown University","sponsor_slug":"georgetown-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04029974","publication_url":"https://clinicaltrials.gov/study/NCT04029974","title":"Does the Speed of Robotic Leg Movements During Tilt-table Verticalization Affect Orthostatic Hypotension in Persons With Subacute SCI","has_exemption":false,"start_date":"2019-08-20","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Methodist Rehabilitation Center","sponsor_slug":"methodist-rehabilitation-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03945162","publication_url":"https://clinicaltrials.gov/study/NCT03945162","title":"A Phase II Clinical Study of Intravesical Ruvidar® in Patients With BCG-Unresponsive Non-Muscle Invasive Bladder Cancer (\"NMIBC\") Carcinoma In-Situ (\"CIS\") or Patients Who Are Intolerant to BCG Therapy (\"Study II\")","has_exemption":false,"start_date":"2019-08-30","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Theralase Technologies Inc.","sponsor_slug":"theralase-technologies-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03683186","publication_url":"https://clinicaltrials.gov/study/NCT03683186","title":"A Phase 3 Open-label Extension (OLE) Study to Evaluate the Long-term Safety and Efficacy of Ralinepag in Subjects With World Health Organization (WHO) Group 1 Pulmonary Arterial Hypertension (PAH)","has_exemption":false,"start_date":"2019-09-23","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"United Therapeutics","sponsor_slug":"united-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04130516","publication_url":"https://clinicaltrials.gov/study/NCT04130516","title":"A Multicenter Phase 1-2A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Antitumor Activity of LNS8801 in Patients With Advanced Cancer With and Without Pembrolizumab","has_exemption":false,"start_date":"2019-10-21","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Linnaeus Therapeutics, Inc.","sponsor_slug":"linnaeus-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04020276","publication_url":"https://clinicaltrials.gov/study/NCT04020276","title":"A Phase I Study of OAR-Based, Dose Escalated SBRT With Real Time Adaptive MRI Guidance for Liver Metastases","has_exemption":false,"start_date":"2019-11-04","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"University of Wisconsin, Madison","sponsor_slug":"university-of-wisconsin-madison","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04145375","publication_url":"https://clinicaltrials.gov/study/NCT04145375","title":"Continuation Protocol for ZEN003694 in Patients Experiencing Clinical Benefit While Enrolled in a ZEN003694 Protocol","has_exemption":false,"start_date":"2019-11-12","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Zenith Epigenetics","sponsor_slug":"zenith-epigenetics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04128709","publication_url":"https://clinicaltrials.gov/study/NCT04128709","title":"Measurement of Bladder Pressure With a Novel External Device (Cystomanometer) - Home Use","has_exemption":false,"start_date":"2019-11-19","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Christopher Cooper","sponsor_slug":"christopher-cooper","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04197921","publication_url":"https://clinicaltrials.gov/study/NCT04197921","title":"A Feasibility Clinical Trial of Exablate for Low Intensity Focused Ultrasound Neuromodulation in Patients With Opioid Use Disorder (OUD) and/or Other Substance Abuse Disorders (SUDs)","has_exemption":false,"start_date":"2019-11-27","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"InSightec","sponsor_slug":"insightec","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT02846571","publication_url":"https://clinicaltrials.gov/study/NCT02846571","title":"Pancreatic Islet Transplantation Into the Anterior Chamber of the Eye","has_exemption":false,"start_date":"2019-12-05","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Midhat H. Abdulreda","sponsor_slug":"midhat-h-abdulreda","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04166877","publication_url":"https://clinicaltrials.gov/study/NCT04166877","title":"Magnesium Infusion for Pain Management in Critically Ill Trauma Patients","has_exemption":false,"start_date":"2019-12-07","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"University of California, Davis","sponsor_slug":"university-of-california-davis","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04164641","publication_url":"https://clinicaltrials.gov/study/NCT04164641","title":"Noraxon myoRESEARCH™ Software Gait Analysis Evaluation and Orthotic Gait Correction in Reducing Diabetic Foot Ulceration Or Subsequent Amputation in Patients With a History of a Diabetic Foot Ulceration","has_exemption":false,"start_date":"2019-12-09","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Johns Hopkins University","sponsor_slug":"johns-hopkins-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04115631","publication_url":"https://clinicaltrials.gov/study/NCT04115631","title":"A Randomized 3-Arm Phase II Study Comparing 1.) Bendamustine, Rituximab and High Dose Cytarabine (BR/CR) 2.) Bendamustine, Rituximab, High Dose Cytarabine and Acalabrutinib (BR/CR-A), and 3.) Bendamustine, Rituximab and Acalabrutinib (BR-A) in Patients </= 70 Years Old With Untreated Mantle Cell Lymphoma","has_exemption":false,"start_date":"2019-12-13","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"ECOG-ACRIN Cancer Research Group","sponsor_slug":"ecog-acrin-cancer-research-group","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04128995","publication_url":"https://clinicaltrials.gov/study/NCT04128995","title":"Surgical or Medical Treatment for Pediatric Type 2 Diabetes","has_exemption":false,"start_date":"2019-12-15","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Children's Hospital Medical Center, Cincinnati","sponsor_slug":"childrens-hospital-medical-center-cincinnati","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04239625","publication_url":"https://clinicaltrials.gov/study/NCT04239625","title":"A Phase 2 Multicenter, Double-Masked, Randomized, Placebo-Controlled Study to Investigate the Long Term Safety, Tolerability, Pharmacokinetics and Effects of ALK-001 on the Progression of Stargardt Disease","has_exemption":false,"start_date":"2019-12-20","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Alkeus Pharmaceuticals, Inc.","sponsor_slug":"alkeus-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04181684","publication_url":"https://clinicaltrials.gov/study/NCT04181684","title":"Pilot Study of Laser Interstitial Thermal Therapy Followed By Hypofractionated Radiation Therapy for Treatment of Recurrent Gliomas.","has_exemption":false,"start_date":"2020-01-08","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"University of Maryland, Baltimore","sponsor_slug":"university-of-maryland-baltimore","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04205370","publication_url":"https://clinicaltrials.gov/study/NCT04205370","title":"Sleep Behaviors in Pregnancy","has_exemption":false,"start_date":"2020-01-22","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"University of Michigan","sponsor_slug":"university-of-michigan","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04187105","publication_url":"https://clinicaltrials.gov/study/NCT04187105","title":"BMT-06: Phase II Study of Intensity Modulated Total Marrow Irradiation (IM-TMI) in Addition to Fludarabine/Cyclophosphamide and Post-Transplant Cyclophosphamide Conditioning for Partially HLA Mismatched Allogeneic Transplantation in Patients With Acute Leukemia and Myelodysplastic Syndrome (MDS)","has_exemption":false,"start_date":"2020-01-27","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"University of Illinois at Chicago","sponsor_slug":"university-of-illinois-at-chicago","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04623931","publication_url":"https://clinicaltrials.gov/study/NCT04623931","title":"Phase II Trial of Treatment Intensification for IDH Wildtype, Non-Histological Glioblastoma, Gliomas (IDH Wildtype Lower Grade Glioma Treatment Intensification)","has_exemption":false,"start_date":"2020-01-30","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05406999","publication_url":"https://clinicaltrials.gov/study/NCT05406999","title":"A Prospective, Multi-arm, Multi-center Clinical Trial on Neoadjuvant Intense Endocrine Therapy for High Risk and Locally Advanced Prostate Cancer","has_exemption":false,"start_date":"2020-02-01","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School","sponsor_slug":"the-affiliated-nanjing-drum-tower-hospital-of-nanjing-university-medical-school","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04068753","publication_url":"https://clinicaltrials.gov/study/NCT04068753","title":"Phase II Trial of Niraparib in Combination With Dostarlimab in Patients With Recurrent or Progressive Cervix Cancer (OU-SCC-STAR)","has_exemption":false,"start_date":"2020-02-26","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"University of Oklahoma","sponsor_slug":"university-of-oklahoma","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03804944","publication_url":"https://clinicaltrials.gov/study/NCT03804944","title":"Converting HR+ Breast Cancer Into an Individualized Vaccine","has_exemption":false,"start_date":"2020-03-17","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Weill Medical College of Cornell University","sponsor_slug":"weill-medical-college-of-cornell-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04251416","publication_url":"https://clinicaltrials.gov/study/NCT04251416","title":"A Phase II Evaluation of Sacituzumab Govitecan (IMMU-132), an Anti-Trop-2-SN-38 Antibody-drug Conjugate, in Patients With Persistent or Recurrent Endometrial Carcinoma","has_exemption":false,"start_date":"2020-03-17","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Yale University","sponsor_slug":"yale-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04256018","publication_url":"https://clinicaltrials.gov/study/NCT04256018","title":"A Phase 2 Single Center, Single Arm, Open Label Mogamulizumab Combined Upfront With Low Dose Total Skin Electron Beam Therapy (LD TSEBT) in Patients With Mycosis Fungoides (MF) and Sézary Syndrome (SS)","has_exemption":false,"start_date":"2020-03-30","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Stanford University","sponsor_slug":"stanford-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03803553","publication_url":"https://clinicaltrials.gov/study/NCT03803553","title":"Early Identification and Treatment of Occult Metastatic Disease in Stage III Colon Cancer","has_exemption":false,"start_date":"2020-04-16","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04128501","publication_url":"https://clinicaltrials.gov/study/NCT04128501","title":"A Phase II Study of Venetoclax in Combination With Azacitidine in the Post-Transplant Setting for AML, T Cell Leukemia, and Mixed Phenotype Acute Leukemia","has_exemption":false,"start_date":"2020-05-05","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04190589","publication_url":"https://clinicaltrials.gov/study/NCT04190589","title":"A Single Center Prospective Study Comparing Robot-assisted and Open Operation With Complete Mesocolic Excision (CME) in Extended Right Colectomy for Colon Cancer in the Right Flexure and Transverse Colon","has_exemption":false,"start_date":"2020-05-18","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Vejle Hospital","sponsor_slug":"vejle-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04240821","publication_url":"https://clinicaltrials.gov/study/NCT04240821","title":"Open-Label Extension Study of Theophylline for Treatment of Pseudohypoparathyroidism","has_exemption":false,"start_date":"2020-05-22","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Jaclyn Tamaroff","sponsor_slug":"jaclyn-tamaroff","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04093167","publication_url":"https://clinicaltrials.gov/study/NCT04093167","title":"A Biomarker-Directed, Multi-Centre Phase II/III Study of CTDNA Response Adaptive Immuno-Chemotherapy in Lung Cancer","has_exemption":false,"start_date":"2020-05-26","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Canadian Cancer Trials Group","sponsor_slug":"canadian-cancer-trials-group","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04216524","publication_url":"https://clinicaltrials.gov/study/NCT04216524","title":"Phase 2 Clinical Trial for Comprehensive Treatment Program for Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): Tagraxofusp (SL-401) in Combination With HCVAD/Mini-CVD and VENETOCLAX","has_exemption":false,"start_date":"2020-05-29","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04209660","publication_url":"https://clinicaltrials.gov/study/NCT04209660","title":"A Phase II Study of Lenvatinib Plus Pembrolizumab in Patients With Progressive, Recurrent/Metastatic Adenoid Cystic Carcinoma and Other Salivary Gland Cancers","has_exemption":false,"start_date":"2020-06-02","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04184973","publication_url":"https://clinicaltrials.gov/study/NCT04184973","title":"Efficacy and Safety of the CG-100 Intraluminal Bypass Device in Colorectal and Coloanal Anastomoses: Prospective, Open Label, Randomized Trial","has_exemption":false,"start_date":"2020-06-23","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Colospan Ltd.","sponsor_slug":"colospan-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04115163","publication_url":"https://clinicaltrials.gov/study/NCT04115163","title":"A Pilot Study of Biologically Optimized Infusion Schedule of Gemcitabine and Nab-Paclitaxel in Metastatic Pancreatic Adenocarcinoma","has_exemption":false,"start_date":"2020-06-24","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Anne Noonan","sponsor_slug":"anne-noonan","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04197596","publication_url":"https://clinicaltrials.gov/study/NCT04197596","title":"A Pilot Study in the Treatment of Refractory BK Infections With Related Donor BK Specific Cytotoxic T-cells (CTLs) in Children, Adolescents and Young Adult Recipients","has_exemption":false,"start_date":"2020-07-01","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"New York Medical College","sponsor_slug":"new-york-medical-college","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04375384","publication_url":"https://clinicaltrials.gov/study/NCT04375384","title":"Pilot Phase II Study to Evaluate Effect of Cetuximab Given as Single Agent After Immunotherapy With PD-1 Inhibitors in Patients With Head and Neck Squamous Cell Carcinoma","has_exemption":false,"start_date":"2020-07-01","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Wake Forest University Health Sciences","sponsor_slug":"wake-forest-university-health-sciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04478279","publication_url":"https://clinicaltrials.gov/study/NCT04478279","title":"A Phase 1-2 Dose-escalation and Expansion Study of ST101 in Patients With Advanced Unresectable and Metastatic Solid Tumors","has_exemption":false,"start_date":"2020-07-01","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Sapience Therapeutics","sponsor_slug":"sapience-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04562194","publication_url":"https://clinicaltrials.gov/study/NCT04562194","title":"NEVA ONE One-Pass Reperfusion With the NeVa Stent-Retriever EMEA Registry","has_exemption":false,"start_date":"2020-07-01","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Vesalio","sponsor_slug":"vesalio","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03266653","publication_url":"https://clinicaltrials.gov/study/NCT03266653","title":"A Pilot Study in the Treatment of Refractory Epstein-Barr Virus (EBV) Infection With Related Donor EBV Cytotoxic T-Lymphocytes in Children, Adolescents and Young Adult Recipients","has_exemption":false,"start_date":"2020-07-07","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"New York Medical College","sponsor_slug":"new-york-medical-college","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04560673","publication_url":"https://clinicaltrials.gov/study/NCT04560673","title":"Optimizing Neurofeedback to Treat Chemotherapy Induced Peripheral Neuropathy","has_exemption":false,"start_date":"2020-07-10","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04150640","publication_url":"https://clinicaltrials.gov/study/NCT04150640","title":"Phase 2 Trial of 5-Fluorouracil, Oxaliplatin and Liposomal Irinotecan and Immunotherapy (Plus Trastuzumab for HER2-positive Disease) During 1st Line Treatment of Advanced Esophageal and Gastric Adenocarcinoma","has_exemption":false,"start_date":"2020-07-13","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"University of Wisconsin, Madison","sponsor_slug":"university-of-wisconsin-madison","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04310007","publication_url":"https://clinicaltrials.gov/study/NCT04310007","title":"A Randomized Phase II Trial of Cabozantinib and Cabozantinib Plus Nivolumab Versus Standard Chemotherapy in Patients With Previously Treated Non-Squamous NSCLC","has_exemption":false,"start_date":"2020-07-13","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04551170","publication_url":"https://clinicaltrials.gov/study/NCT04551170","title":"Phase 2 Study of Theophylline Treatment for Pseudohypoparathyroidism","has_exemption":false,"start_date":"2020-07-13","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Vanderbilt University Medical Center","sponsor_slug":"vanderbilt-university-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04861714","publication_url":"https://clinicaltrials.gov/study/NCT04861714","title":"Evaluation of Regeneten Augmentation for Subscapularis Healing After Total Shoulder Arthroplasty (RESTOR)","has_exemption":false,"start_date":"2020-07-14","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Ohio State University","sponsor_slug":"ohio-state-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04055428","publication_url":"https://clinicaltrials.gov/study/NCT04055428","title":"The Effects of Natriuretic Peptide Augmentation on Cardiometabolic Health in Black Individuals (NAUTICAL)","has_exemption":false,"start_date":"2020-08-15","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"University of Alabama at Birmingham","sponsor_slug":"university-of-alabama-at-birmingham","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04388332","publication_url":"https://clinicaltrials.gov/study/NCT04388332","title":"Comparison of Clinical Outcomes Following ACDF With Instrumentation Using Structural Allograft vs. Tritanium C","has_exemption":false,"start_date":"2020-08-20","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)","sponsor_slug":"allegheny-singer-research-institute-also-known-as-allegheny-health-network-research-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04239157","publication_url":"https://clinicaltrials.gov/study/NCT04239157","title":"A Phase II, Open-Label, Study of Subcutaneous Canakinumab, an Anti-IL-1β Human Monoclonal Antibody, for Patients With Low or Int-1 Risk IPSS/IPSS-R Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia","has_exemption":false,"start_date":"2020-08-25","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04466683","publication_url":"https://clinicaltrials.gov/study/NCT04466683","title":"Phase II Protocol of Low-Dose Whole Thorax Megavoltage Radiotherapy for Patients With SARS-COV-2 Pneumonia","has_exemption":false,"start_date":"2020-08-28","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Ohio State University","sponsor_slug":"ohio-state-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04516070","publication_url":"https://clinicaltrials.gov/study/NCT04516070","title":"Stereotactic Radiosurgery (SRS) as Definitive Management for a Limited Number of Small Cell Lung Cancer (SCLC) Brain Metastasis","has_exemption":false,"start_date":"2020-08-28","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04466150","publication_url":"https://clinicaltrials.gov/study/NCT04466150","title":"Impact of Ocrelizumab on Cerebrospinal Fluid Biomarkers at Multiple Sclerosis Onset","has_exemption":false,"start_date":"2020-08-30","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"University of California, San Francisco","sponsor_slug":"university-of-california-san-francisco","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04262206","publication_url":"https://clinicaltrials.gov/study/NCT04262206","title":"PRagmatic EValuation of evENTs And Benefits of Lipid-lowering in oldEr Adults (PREVENTABLE)","has_exemption":false,"start_date":"2020-09-01","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Duke University","sponsor_slug":"duke-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03935295","publication_url":"https://clinicaltrials.gov/study/NCT03935295","title":"Dysport ® (abobotulinumtoxinA) as an Adjunctive Treatment to Bracing in the Management of Adolescent Idiopathic Scoliosis","has_exemption":false,"start_date":"2020-09-03","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Johns Hopkins University","sponsor_slug":"johns-hopkins-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04442022","publication_url":"https://clinicaltrials.gov/study/NCT04442022","title":"A Phase 2/3, Multicenter Randomized Study of Rituximab-Gemcitabine-Dexamethasone-Platinum (R-GDP) With or Without Selinexor in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma (RR DLBCL)","has_exemption":false,"start_date":"2020-09-03","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Karyopharm Therapeutics Inc","sponsor_slug":"karyopharm-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04373473","publication_url":"https://clinicaltrials.gov/study/NCT04373473","title":"A Phase 2a, Randomized, Double-blinded, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Lyophilized Fecal Microbiota Transplantation (PRIM-DJ2727) Administered Orally in Combination With Standard of Care Therapy for Prevention of Relapse or Intestinal Inflammation in Adults With Ulcerative Colitis","has_exemption":false,"start_date":"2020-09-14","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"The University of Texas Health Science Center, Houston","sponsor_slug":"the-university-of-texas-health-science-center-houston","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04553133","publication_url":"https://clinicaltrials.gov/study/NCT04553133","title":"PHASE 1/2A DOSE ESCALATION, FINDING AND EXPANSION STUDY EVALUATING SAFETY, TOLERABILITY, PHARMACOKINETICS, PHARMACODYNAMICS AND ANTI TUMOR ACTIVITY OF PF-07104091 AS A SINGLE AGENT AND IN COMBINATION THERAPY","has_exemption":false,"start_date":"2020-09-16","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Pfizer","sponsor_slug":"pfizer","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04861103","publication_url":"https://clinicaltrials.gov/study/NCT04861103","title":"Anticoagulation Profile in Pregnant Women Treated With Three Times a Day of Low Molecular Weight Heparin (LMWH)","has_exemption":false,"start_date":"2020-10-01","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"University of California, Irvine","sponsor_slug":"university-of-california-irvine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03654053","publication_url":"https://clinicaltrials.gov/study/NCT03654053","title":"Effect of Simvastatin on Hepatic Decompensation and Death in Subjects With High-risk Compensated Cirrhosis","has_exemption":false,"start_date":"2020-10-02","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"VA Office of Research and Development","sponsor_slug":"va-office-of-research-and-development","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04553770","publication_url":"https://clinicaltrials.gov/study/NCT04553770","title":"A Phase II, Multicenter, Open-Label Trial to Evaluate the Safety and Efficacy of Trastuzumab Deruxtecan (DS-8201a) With or Without Anastrozole for HER2 Low Hormone Receptor Positive (HR+) Breast Cancer in the Neoadjuvant Setting","has_exemption":false,"start_date":"2020-10-09","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Jonsson Comprehensive Cancer Center","sponsor_slug":"jonsson-comprehensive-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05011331","publication_url":"https://clinicaltrials.gov/study/NCT05011331","title":"The Effect of a Custom Pillow on Sleep Quality in Patients With Nonoperative Rotator Cuff Syndrome: a Prospective Randomized Study","has_exemption":false,"start_date":"2020-10-13","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Rhode Island Hospital","sponsor_slug":"rhode-island-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04009109","publication_url":"https://clinicaltrials.gov/study/NCT04009109","title":"A Phase II Study of Lenalidomide, Ixazomib, Dexamethasone, and Daratumumab in Transplant-Ineligible Patients With Newly Diagnosed Multiple Myeloma","has_exemption":false,"start_date":"2020-10-21","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Alliance Foundation Trials, LLC.","sponsor_slug":"alliance-foundation-trials-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04528680","publication_url":"https://clinicaltrials.gov/study/NCT04528680","title":"Phase 1 / 2 Trial of Blood-brain Barrier Opening With an Implantable Ultrasound Device SonoCloud-9 and Treatment With Albumin-bound Paclitaxel and Carboplatin in Patients With Recurrent Glioblastoma","has_exemption":false,"start_date":"2020-10-29","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Northwestern University","sponsor_slug":"northwestern-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04235257","publication_url":"https://clinicaltrials.gov/study/NCT04235257","title":"Immunogenicity of Fractional Dose of the Bivalent and Nonavalent Intradermal HPV Vaccines.","has_exemption":false,"start_date":"2020-11-01","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"University of Washington","sponsor_slug":"university-of-washington","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04504123","publication_url":"https://clinicaltrials.gov/study/NCT04504123","title":"MMP-9 Inhibition for Recalcitrant Wet Age-Related Macular Degeneration (AMD)","has_exemption":false,"start_date":"2020-11-04","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"University of Iowa","sponsor_slug":"university-of-iowa","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04427709","publication_url":"https://clinicaltrials.gov/study/NCT04427709","title":"Generate and Test the Reliability of a Pharmacodynamic Model of Oxytocin on Pupillary Hippus as a Measure of Central Nervous System Activity","has_exemption":false,"start_date":"2020-11-30","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Wake Forest University Health Sciences","sponsor_slug":"wake-forest-university-health-sciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04587687","publication_url":"https://clinicaltrials.gov/study/NCT04587687","title":"A Phase II Study of Brentuximab Vedotin Plus Bendamustine for Relapsed/Refractory Follicular Lymphoma","has_exemption":false,"start_date":"2020-12-04","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Joseph Tuscano","sponsor_slug":"joseph-tuscano","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04661007","publication_url":"https://clinicaltrials.gov/study/NCT04661007","title":"A Phase 1b/2 Study of Tafasitamab, Tafasitamab Plus Lenalidomide, Tafasitamab Plus Parsaclisib, and Tafasitamab Plus Lenalidomide in Combination With R-CHOP in Japanese Participants With Non-Hodgkin Lymphoma","has_exemption":false,"start_date":"2020-12-15","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Incyte Biosciences Japan GK","sponsor_slug":"incyte-biosciences-japan-gk","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04331769","publication_url":"https://clinicaltrials.gov/study/NCT04331769","title":"Randomized Clinical Evaluation of the AccuCinch® Ventricular Restoration System in Patients Who Present With Symptomatic Heart Failure With Reduced Ejection Fraction (HFrEF): The CORCINCH-HF Study","has_exemption":false,"start_date":"2020-12-21","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Ancora Heart, Inc.","sponsor_slug":"ancora-heart-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04678895","publication_url":"https://clinicaltrials.gov/study/NCT04678895","title":"Low-Dose Naltrexone for the Treatment of Painful Diabetic Neuropathy, a Small, Randomized, Double-blind, Placebo-controlled Crossover Trial","has_exemption":false,"start_date":"2020-12-22","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Dartmouth-Hitchcock Medical Center","sponsor_slug":"dartmouth-hitchcock-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04145115","publication_url":"https://clinicaltrials.gov/study/NCT04145115","title":"A Phase II Study of Checkpoint Blockade Immunotherapy in Patients With Somatically Hypermutated Recurrent WHO Grade 4 Glioma","has_exemption":false,"start_date":"2020-12-24","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04690348","publication_url":"https://clinicaltrials.gov/study/NCT04690348","title":"Intracavitary Carrier-embedded Cs131 Brachytherapy for Recurrent Brain Metastases: a Randomized Phase II Study","has_exemption":false,"start_date":"2020-12-24","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04181060","publication_url":"https://clinicaltrials.gov/study/NCT04181060","title":"Randomized Phase III Study of Combination Osimertinib (AZD9291) and Bevacizumab Versus Osimertinib (AZD9291) Alone as First-Line Treatment for Patients With Metastatic EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC)","has_exemption":false,"start_date":"2020-12-28","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04704921","publication_url":"https://clinicaltrials.gov/study/NCT04704921","title":"A Randomized, Partially Masked, Controlled, Phase 2b/3 Clinical Study to Evaluate the Efficacy and Safety of RGX-314 Gene Therapy in Participants With nAMD (ATMOSPHERE)","has_exemption":false,"start_date":"2020-12-29","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"AbbVie","sponsor_slug":"abbvie","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04339699","publication_url":"https://clinicaltrials.gov/study/NCT04339699","title":"STITCH - Prospective Multi Center Comparative Parallel Concurrent Study of the NobleStitch EL Compared to FDA Approved Amplatzer Occluder Device for Closure of Patent Foramen Ovale to Prevent Recurrent Ischemic Stroke","has_exemption":false,"start_date":"2021-01-01","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Nobles Medical Technologies II Inc","sponsor_slug":"nobles-medical-technologies-ii-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04771520","publication_url":"https://clinicaltrials.gov/study/NCT04771520","title":"Phase 2 Study of Avapritinib in Patients With CKIT or PDGFRA Mutation-Positive Malignant Solid Tumors","has_exemption":false,"start_date":"2021-01-20","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04752826","publication_url":"https://clinicaltrials.gov/study/NCT04752826","title":"Phase 1/2a Open-Label, Dose-Escalation, Multicenter, FIH, Consecutive-Cohort, Clinical Trial of BI-1808, a Monoclonal Antibody to TNFR 2 as a Single Agent and in Combination With Pembrolizumab (MK-3475-D20) in Subjects With Advanced Malignancies","has_exemption":false,"start_date":"2021-01-25","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"BioInvent International AB","sponsor_slug":"bioinvent-international-ab","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04657068","publication_url":"https://clinicaltrials.gov/study/NCT04657068","title":"A Phase I/IIa, Open-label, Multi-center Study to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of the ATR Kinase Inhibitor ART0380 Administered Orally as Monotherapy and in Combination to Patients With Advanced or Metastatic Solid Tumors","has_exemption":false,"start_date":"2021-01-27","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Artios Pharma Ltd","sponsor_slug":"artios-pharma-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04049539","publication_url":"https://clinicaltrials.gov/study/NCT04049539","title":"Open-Label Phase 2 Trial of Vyxeos in Patients With Intermediate and High-Risk Acute Myeloid Leukemia Who Have Failed an Initial Cycle of Standard Cytarabine and Daunorubicin Chemotherapy","has_exemption":false,"start_date":"2021-01-29","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Ohio State University Comprehensive Cancer Center","sponsor_slug":"ohio-state-university-comprehensive-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04725903","publication_url":"https://clinicaltrials.gov/study/NCT04725903","title":"Extended-Field Lymph Node Proton Irradiation for High Risk Prostate Cancer","has_exemption":false,"start_date":"2021-02-01","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Emory University","sponsor_slug":"emory-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04978571","publication_url":"https://clinicaltrials.gov/study/NCT04978571","title":"A Prospective Study on the Effect of Auricular Percutaneous Electrical Nerve Field Stimulation (PENFS) in Patients With Post Concussion Syndrome (PCS)","has_exemption":false,"start_date":"2021-02-01","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Children's Hospital of Orange County","sponsor_slug":"childrens-hospital-of-orange-county","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04762953","publication_url":"https://clinicaltrials.gov/study/NCT04762953","title":"Phase II Trial of Sequential Systemic Therapy Plus Intraperitoneal Paclitaxel in Gastric/GEJ Cancer Peritoneal Carcinomatosis (STOPGAP)","has_exemption":false,"start_date":"2021-02-18","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"University of California, Irvine","sponsor_slug":"university-of-california-irvine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04506853","publication_url":"https://clinicaltrials.gov/study/NCT04506853","title":"Single-Sided Deafness and Asymmetric Hearing Loss Post-Approval Study","has_exemption":false,"start_date":"2021-02-22","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Med-El Corporation","sponsor_slug":"med-el-corporation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04633252","publication_url":"https://clinicaltrials.gov/study/NCT04633252","title":"A Phase I/II Study of PDS01ADC With Docetaxel and Abiraterone in Adults With Metastatic Castration Sensitive and PDS01ADC With Docetaxel in Castration Resistant Prostate Cancer","has_exemption":false,"start_date":"2021-02-23","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04609280","publication_url":"https://clinicaltrials.gov/study/NCT04609280","title":"A Single-arm, Single-stage Phase II Trial of Selective Avoidance of Nodal VolumEs at Minimal Risk (SAVER) in the Contralateral Neck of Patients With p16-positive Oropharynx Cancer","has_exemption":false,"start_date":"2021-03-01","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"University of Maryland, Baltimore","sponsor_slug":"university-of-maryland-baltimore","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04719156","publication_url":"https://clinicaltrials.gov/study/NCT04719156","title":"Evaluation of Intraoperative Tumor Margin Identification With Fluorescent Dye Imaging","has_exemption":false,"start_date":"2021-03-02","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Kurt Weiss","sponsor_slug":"kurt-weiss","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04408430","publication_url":"https://clinicaltrials.gov/study/NCT04408430","title":"The Safety and Effectiveness of the Edwards SAPIEN 3, SAPIEN 3 Ultra, and SAPIEN 3 Ultra RESILIA (SAPIEN 3/Ultra/RESILIA) Valve in Patients With Symptomatic Severe Calcific Mitral Valve Disease With Severe Mitral Annular Calcification Who Are Not Candidates for Standard Mitral Valve Surgery.","has_exemption":false,"start_date":"2021-03-08","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Mayra Guerrero","sponsor_slug":"mayra-guerrero","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03937830","publication_url":"https://clinicaltrials.gov/study/NCT03937830","title":"A Phase II Study of Combined Treatment of Durvalumab, Bevacizumab, Tremelimumab and Transarterial Chemoembolization (TACE) in Subjects With Hepatocellular Carcinoma (HCC) or Biliary Tract Carcinoma (BTC)","has_exemption":false,"start_date":"2021-03-10","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04263831","publication_url":"https://clinicaltrials.gov/study/NCT04263831","title":"Low Dose IL-2 for the Treatment of Crohn's Disease","has_exemption":false,"start_date":"2021-03-11","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Boston Children’s Hospital","sponsor_slug":"boston-childrens-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04691804","publication_url":"https://clinicaltrials.gov/study/NCT04691804","title":"A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Study of Fuzuloparib Combined With Abiraterone Acetate and Prednisone (AA-P) Versus Placebo Combined With AA-P as First-Line Treatment in Patients With Metastatic Castration-Resistant Prostate Cancer","has_exemption":false,"start_date":"2021-03-18","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Jiangsu HengRui Medicine Co., Ltd.","sponsor_slug":"jiangsu-hengrui-medicine-co-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04715568","publication_url":"https://clinicaltrials.gov/study/NCT04715568","title":"Occult Cardiovascular Disease With Chronic Exposure to Secondhand Tobacco Smoke","has_exemption":false,"start_date":"2021-03-30","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"University of California, San Francisco","sponsor_slug":"university-of-california-san-francisco","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04099966","publication_url":"https://clinicaltrials.gov/study/NCT04099966","title":"Allogeneic Stem Cell Transplantation for Malignant and Non-malignant Hematologic Diseases Utilizing Alpha/Beta T Cell and CD19+ B Cell Depletion - NYMC 588","has_exemption":false,"start_date":"2021-04-01","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Mitchell Cairo","sponsor_slug":"mitchell-cairo","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04616781","publication_url":"https://clinicaltrials.gov/study/NCT04616781","title":"Effects of Ketone Ester on Brain Function and Alcohol Consumption in Alcohol Use Disorder","has_exemption":false,"start_date":"2021-04-05","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"University of Pennsylvania","sponsor_slug":"university-of-pennsylvania","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05212129","publication_url":"https://clinicaltrials.gov/study/NCT05212129","title":"Hypermobile Ehlers-Danlos Syndrome: Efficacy of Non-invasive Vagal Nerve Stimulation and Effects on Brain-Gut Physiology","has_exemption":false,"start_date":"2021-04-05","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Medical College of Wisconsin","sponsor_slug":"medical-college-of-wisconsin","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06170541","publication_url":"https://clinicaltrials.gov/study/NCT06170541","title":"Ultra-High Resolution Computed Tomography (CT) vs. Conventional CT for Detecting Obstructive Coronary Artery Disease (CAD) The CORE-COMPARE Pilot Study","has_exemption":false,"start_date":"2021-04-05","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Johns Hopkins University","sponsor_slug":"johns-hopkins-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04625647","publication_url":"https://clinicaltrials.gov/study/NCT04625647","title":"A Phase II Study of AMG 510 in Participants With Previously Treated Stage IV or Recurrent KRAS G12C Mutated Non-Squamous Non-Small Cell Lung Cancer (ECOG-ACRIN LUNG-MAP SUB-STUDY)","has_exemption":false,"start_date":"2021-04-16","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"SWOG Cancer Research Network","sponsor_slug":"swog-cancer-research-network","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05037370","publication_url":"https://clinicaltrials.gov/study/NCT05037370","title":"Topography-guided vs. Wavefront Optimized Corneal Refractive Surgery: A Prospective Contralateral Randomized Double-masked Study","has_exemption":false,"start_date":"2021-04-22","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"59th Medical Wing","sponsor_slug":"59th-medical-wing","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04093388","publication_url":"https://clinicaltrials.gov/study/NCT04093388","title":"Self-Collection of the Pap Smear as Agency: A Novel Way to Improve Refractory Low Cervical Cancer Screening Rates in Rural Alabama","has_exemption":false,"start_date":"2021-04-26","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"University of Alabama at Birmingham","sponsor_slug":"university-of-alabama-at-birmingham","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04610294","publication_url":"https://clinicaltrials.gov/study/NCT04610294","title":"Operating Room Air Filtration/Sterilization and Surgical Site Infection: A Randomized Multiple Cross-over Cluster Trial","has_exemption":false,"start_date":"2021-05-01","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"The Cleveland Clinic","sponsor_slug":"the-cleveland-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04783155","publication_url":"https://clinicaltrials.gov/study/NCT04783155","title":"Effect of Inspiratory Muscle Training on Physiological Function and Clinical Outcomes After Lung Transplant: A Randomized Controlled Trial","has_exemption":false,"start_date":"2021-05-10","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04840979","publication_url":"https://clinicaltrials.gov/study/NCT04840979","title":"Discovery and Validation of Genetic Variants Affecting Microglial Activation in Alzheimer's Disease With 11C-ER176","has_exemption":false,"start_date":"2021-05-11","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Columbia University","sponsor_slug":"columbia-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06596252","publication_url":"https://clinicaltrials.gov/study/NCT06596252","title":"Double-blind, Randomized, Non-inferiority Phase III Trial on the Efficacy and Tolerability of 2 mg Once Daily vs. 1 mg Twice Daily Budesonide Orodispersible Tablets in Adults With Eosinophilic Esophagitis","has_exemption":false,"start_date":"2021-05-21","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Dr. Falk Pharma GmbH","sponsor_slug":"dr-falk-pharma-gmbh","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04792489","publication_url":"https://clinicaltrials.gov/study/NCT04792489","title":"A Multi-center Single Arm Phase II Study to Evaluate the Safety and Efficacy of Genetically Engineered Autologous Cells Expressing Anti-CD20 and Anti-CD19 Specific Chimeric Antigen Receptor in Subjects With Relapsed and/or Refractory Diffuse Large B Cell Lymphoma","has_exemption":false,"start_date":"2021-05-25","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Miltenyi Biomedicine GmbH","sponsor_slug":"miltenyi-biomedicine-gmbh","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04870762","publication_url":"https://clinicaltrials.gov/study/NCT04870762","title":"A Randomized Study of Head and Neck Radiotherapy With or Without Customized 3D Printed Oral Stents","has_exemption":false,"start_date":"2021-05-26","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07006675","publication_url":"https://clinicaltrials.gov/study/NCT07006675","title":"Effect of NSAIDs on Union, Opioid Utilization and Pain Management for Tibia Fractures: A Pragmatic, Randomized Controlled Trial","has_exemption":false,"start_date":"2021-05-26","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Major Extremity Trauma Research Consortium","sponsor_slug":"major-extremity-trauma-research-consortium","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04305769","publication_url":"https://clinicaltrials.gov/study/NCT04305769","title":"Alanyl-glutamine Supplementation of Standard Treatment for C. Difficile Infection: a Randomized, Double-blind, Placebo-controlled Trial","has_exemption":false,"start_date":"2021-06-01","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"University of Virginia","sponsor_slug":"university-of-virginia","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04464980","publication_url":"https://clinicaltrials.gov/study/NCT04464980","title":"NIDA-CTN-0100: Optimizing Retention, Duration and Discontinuation Strategies for Opioid Use Disorder Pharmacotherapy (RDD)","has_exemption":false,"start_date":"2021-06-08","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"NYU Langone Health","sponsor_slug":"nyu-langone-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05095740","publication_url":"https://clinicaltrials.gov/study/NCT05095740","title":"The Effects of Neuromodulation on Phonatory Function in Laryngeal Dystonia","has_exemption":false,"start_date":"2021-06-10","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"MGH Institute of Health Professions","sponsor_slug":"mgh-institute-of-health-professions","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04860141","publication_url":"https://clinicaltrials.gov/study/NCT04860141","title":"Efficacy of Preoperative Administration of Gabapentin in Managing Intraoperative and Postoperative Pain From Third Molar Extractions.","has_exemption":false,"start_date":"2021-06-16","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Loma Linda University","sponsor_slug":"loma-linda-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04783441","publication_url":"https://clinicaltrials.gov/study/NCT04783441","title":"Continuous Glucose Monitoring (CGM) to Improve Glycemic Control in Kidney Transplant Recipients","has_exemption":false,"start_date":"2021-06-29","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"University of California, Davis","sponsor_slug":"university-of-california-davis","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04998916","publication_url":"https://clinicaltrials.gov/study/NCT04998916","title":"MPFC Theta Burst Stimulation as a Treatment Tool for Alcohol Use Disorder: Effects on Drinking and Incentive Salience","has_exemption":false,"start_date":"2021-07-06","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Medical University of South Carolina","sponsor_slug":"medical-university-of-south-carolina","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04948203","publication_url":"https://clinicaltrials.gov/study/NCT04948203","title":"SECOVID: A Multi-center, Randomized, Dose-ranging Parallel-group Trial Assessing the Efficacy of Sirolimus in Hospitalized Patients With COVID-19 Pneumonia for the Prevention of Post-COVID Fibrosis","has_exemption":false,"start_date":"2021-07-09","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"University of Chicago","sponsor_slug":"university-of-chicago","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04870255","publication_url":"https://clinicaltrials.gov/study/NCT04870255","title":"Modulating Probabilities: Prediction, Assessment, and Treatment of Acute Mood Depressive Episode in Borderline Personality Disorder With rTMS","has_exemption":false,"start_date":"2021-07-20","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Stanford University","sponsor_slug":"stanford-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04934683","publication_url":"https://clinicaltrials.gov/study/NCT04934683","title":"Tight Perioperative Blood Pressure Management to Reduce Serious Cardiovascular, Renal, and Cognitive Complications: The GUARDIAN Trial (Induction Agent Sub-Study Comparing Etomidate and Propofol)","has_exemption":false,"start_date":"2021-07-25","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"The University of Texas Health Science Center, Houston","sponsor_slug":"the-university-of-texas-health-science-center-houston","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04934748","publication_url":"https://clinicaltrials.gov/study/NCT04934748","title":"Tight Perioperative Blood Pressure Management to Reduce Serious Cardiovascular, Renal, and Cognitive Complications: The GUARDIAN Trial (Vasopressor Sub-study Comparing Phenylephrine and Norepinephrine)","has_exemption":false,"start_date":"2021-07-25","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"The University of Texas Health Science Center, Houston","sponsor_slug":"the-university-of-texas-health-science-center-houston","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04557891","publication_url":"https://clinicaltrials.gov/study/NCT04557891","title":"Feasibility of Low-Intensity Focused Ultrasound Pulsation (LIFUP) for the Treatment of Generalized Anxiety Disorder (GAD)","has_exemption":false,"start_date":"2021-07-26","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"University of California, Los Angeles","sponsor_slug":"university-of-california-los-angeles","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04959526","publication_url":"https://clinicaltrials.gov/study/NCT04959526","title":"Comparison of Shear-wave Elastography to State-of-the-art Respiratory Function Testing to Measure the Range of Forces Generated by the Diaphragm Muscle","has_exemption":false,"start_date":"2021-07-28","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04883242","publication_url":"https://clinicaltrials.gov/study/NCT04883242","title":"Isa-CAPED MM: Isatuximab, Carfilzomib, Pomalidomide, and Dexamethasone (Isa-KPd) for Patients With Relapsed/Refractory Multiple Myeloma","has_exemption":false,"start_date":"2021-07-29","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"University of Washington","sponsor_slug":"university-of-washington","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04957719","publication_url":"https://clinicaltrials.gov/study/NCT04957719","title":"Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of Self-administered Subcutaneous Selatogrel for Prevention of All-cause Death and Treatment of Acute Myocardial Infarction in Subjects With a Recent History of Acute Myocardial Infarction","has_exemption":false,"start_date":"2021-08-14","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Viatris Innovation GmbH","sponsor_slug":"viatris-innovation-gmbh","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04912323","publication_url":"https://clinicaltrials.gov/study/NCT04912323","title":"The R3 Vascular Drug-Eluting Bioresorbable Scaffold in Below the Knee Vessels Trial (RESOLV I)","has_exemption":false,"start_date":"2021-08-17","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"R3 Vascular Inc.","sponsor_slug":"r3-vascular-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04968990","publication_url":"https://clinicaltrials.gov/study/NCT04968990","title":"Multi-Center Trial Sponsored by St. Jude Children's Research Hospital for the Treatment of Newly Diagnosed Patient's With Wilm's Tumor Requiring Abdominal Radiation Delivered With Proton Beam Irradiation","has_exemption":false,"start_date":"2021-08-19","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"St. Jude Children's Research Hospital","sponsor_slug":"st-jude-childrens-research-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04724252","publication_url":"https://clinicaltrials.gov/study/NCT04724252","title":"Gabapentin to Reduce Opioid Use Postoperatively (GROUP) in Children","has_exemption":false,"start_date":"2021-08-23","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"University of California, Davis","sponsor_slug":"university-of-california-davis","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05004129","publication_url":"https://clinicaltrials.gov/study/NCT05004129","title":"An Open-Label Study to Evaluate the Long-Term Safety and Efficacy of Tideglusib for the Treatment of Congenital or Childhood Onset DM1 (REACH CDM X)","has_exemption":false,"start_date":"2021-08-23","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"AMO Pharma Limited","sponsor_slug":"amo-pharma-limited","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04880226","publication_url":"https://clinicaltrials.gov/study/NCT04880226","title":"Evaluation of Non Significant Risk Operation Magnetic Resonance Imaging for MR Guided Ablation Using the Philips MRI","has_exemption":false,"start_date":"2021-08-30","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03952299","publication_url":"https://clinicaltrials.gov/study/NCT03952299","title":"Oxybutynin for Post-surgical Bladder Pain and Urgency","has_exemption":false,"start_date":"2021-09-01","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"University of California, Davis","sponsor_slug":"university-of-california-davis","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04867837","publication_url":"https://clinicaltrials.gov/study/NCT04867837","title":"Study of Four-factor Prothrombin Complex Concentrate, OCTAPLEX, in Patients With Acute Major Bleeding on Direct Oral Anticoagulant (DOAC) Therapy With Factor Xa Inhibitor","has_exemption":false,"start_date":"2021-09-01","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Octapharma","sponsor_slug":"octapharma","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05012631","publication_url":"https://clinicaltrials.gov/study/NCT05012631","title":"Losartan for Diffuse Myocardial Fibrosis in Sickle Cell Disease: A Prospective, Phase II Study.","has_exemption":false,"start_date":"2021-09-01","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Children's Hospital Medical Center, Cincinnati","sponsor_slug":"childrens-hospital-medical-center-cincinnati","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05178017","publication_url":"https://clinicaltrials.gov/study/NCT05178017","title":"Effectiveness of the Lifestyle Eating and Performance (LEAP) Program for the Treatment of Irritable Bowel Syndrome (IBS)","has_exemption":false,"start_date":"2021-09-01","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Oxford Biomedical Technologies, Inc.","sponsor_slug":"oxford-biomedical-technologies-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05035030","publication_url":"https://clinicaltrials.gov/study/NCT05035030","title":"An Open Label Study to Evaluate the Long-term Safety and Efficacy of Odevixibat (A4250) in Patients With Alagille Syndrome (ASSERT-EXT)","has_exemption":false,"start_date":"2021-09-03","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Albireo, an Ipsen Company","sponsor_slug":"albireo-an-ipsen-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04896606","publication_url":"https://clinicaltrials.gov/study/NCT04896606","title":"A Pilot Study of SARS-CoV-2 Specific Cytotoxic T Lymphocytes (SARS-CoV-2-CTLs) for Treatment of Mild to Moderate Coronavirus Disease 2019 (COVID-19)","has_exemption":false,"start_date":"2021-09-20","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"New York Medical College","sponsor_slug":"new-york-medical-college","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04953104","publication_url":"https://clinicaltrials.gov/study/NCT04953104","title":"A Phase II Clinical Trial to Investigate ARID1A and/or KDM6A Mutation and CXCL13 Expression in the Pre-treatment Tumor Samples as a Combinatorial Predictive Biomarker for Immune Checkpoint Therapy in Metastatic Urothelial Cancer","has_exemption":false,"start_date":"2021-09-21","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04977024","publication_url":"https://clinicaltrials.gov/study/NCT04977024","title":"A Phase 2 Randomized, Multi-center Study of GEO-CMO4S1 (SARS-CoV-2 Vaccine) Versus mRNA SARS-CoV-2 Vaccine in Patients Post Cellular Therapy for Hematological Malignancies","has_exemption":false,"start_date":"2021-09-27","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"GeoVax, Inc.","sponsor_slug":"geovax-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05020574","publication_url":"https://clinicaltrials.gov/study/NCT05020574","title":"Microbiome and Association With Implant Infections: Investigating the Impact of Antibiotics on the Gut and Breast Microbiomes Post-mastectomy With Implant-based Breast Reconstruction","has_exemption":false,"start_date":"2021-09-28","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"University of California, San Francisco","sponsor_slug":"university-of-california-san-francisco","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05079568","publication_url":"https://clinicaltrials.gov/study/NCT05079568","title":"\"A Pilot Study to Assess the Safety, Tolerability and Efficacy of Virtual Reality for the Treatment of Gastroparesis\"","has_exemption":false,"start_date":"2021-10-01","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04759586","publication_url":"https://clinicaltrials.gov/study/NCT04759586","title":"A Randomized Phase 3 Trial of Nivolumab (NSC# 748726) in Combination With Chemo-Immunotherapy for the Treatment of Newly Diagnosed Primary Mediastinal B-Cell Lymphoma","has_exemption":false,"start_date":"2021-10-05","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05063851","publication_url":"https://clinicaltrials.gov/study/NCT05063851","title":"The Use of Memantine for Prevention of Alzheimer's Disease","has_exemption":false,"start_date":"2021-10-11","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"University of Virginia","sponsor_slug":"university-of-virginia","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05124652","publication_url":"https://clinicaltrials.gov/study/NCT05124652","title":"An Automatically-adjusting Prosthetic Socket for People With Transtibial Amputation","has_exemption":false,"start_date":"2021-10-18","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"University of Washington","sponsor_slug":"university-of-washington","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04996173","publication_url":"https://clinicaltrials.gov/study/NCT04996173","title":"Cryospray Therapy for Benign Airway Stenosis: a Randomized Pilot Study","has_exemption":false,"start_date":"2021-10-25","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Vanderbilt University Medical Center","sponsor_slug":"vanderbilt-university-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04829604","publication_url":"https://clinicaltrials.gov/study/NCT04829604","title":"A Global, Phase 2 Study of ARX788 in HER2-positive Metastatic Breast Cancer Patients Who Were Previously Treated With T-DXd","has_exemption":false,"start_date":"2021-10-26","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Ambrx, Inc.","sponsor_slug":"ambrx-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04229758","publication_url":"https://clinicaltrials.gov/study/NCT04229758","title":"Restarting Anticoagulation After Traumatic Intracranial Hemorrhage (Restart tICrH): a Prospective Randomized Open Label Blinded Endpoint (PROBE) Pragmatic Time-dose, Response Adaptive Clinical Trial","has_exemption":false,"start_date":"2021-10-31","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"University of Texas at Austin","sponsor_slug":"university-of-texas-at-austin","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05015881","publication_url":"https://clinicaltrials.gov/study/NCT05015881","title":"Relationship Between Brain and Heart Glucose Metabolism in Alcohol Use Disorder","has_exemption":false,"start_date":"2021-11-01","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"University of Pennsylvania","sponsor_slug":"university-of-pennsylvania","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05110144","publication_url":"https://clinicaltrials.gov/study/NCT05110144","title":"A Randomized, Double-blind, Placebo-controlled, Dose-escalation Study Evaluating the Efficacy of Two Doses of Duloxetine & Amitriptyline in Subjects With Refractory Chronic Cough","has_exemption":false,"start_date":"2021-11-01","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04597372","publication_url":"https://clinicaltrials.gov/study/NCT04597372","title":"The Impact of Tamsulosin on Duration of Post-Operative Urinary Retention in Women Undergoing Pelvic Reconstructive Surgery- A Double Blind, Randomized, Placebo-Controlled Study","has_exemption":false,"start_date":"2021-11-03","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)","sponsor_slug":"allegheny-singer-research-institute-also-known-as-allegheny-health-network-research-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05058287","publication_url":"https://clinicaltrials.gov/study/NCT05058287","title":"Topical Epidural Steroid Usage in Patients Undergoing Posterior Lumbar Decompression: A Randomized Control Trial","has_exemption":false,"start_date":"2021-11-05","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Hospital for Special Surgery, New York","sponsor_slug":"hospital-for-special-surgery-new-york","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05065216","publication_url":"https://clinicaltrials.gov/study/NCT05065216","title":"Phase 2/3 Adaptive Design, Randomized Double-blind Placebo-controlled Study to Evaluate the Safety and Efficacy of DM199 for the Treatment of Acute Ischemic Stroke (ReMEDy2 Trial)","has_exemption":false,"start_date":"2021-11-07","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"DiaMedica Therapeutics Inc","sponsor_slug":"diamedica-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05131178","publication_url":"https://clinicaltrials.gov/study/NCT05131178","title":"Double Blind Randomized Trial of Post-operative Cesarean Continuous Infusion of Bupivacaine Versus Placebo for Local Incisional Pain Control","has_exemption":false,"start_date":"2021-11-07","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"University of Colorado, Denver","sponsor_slug":"university-of-colorado-denver","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04692818","publication_url":"https://clinicaltrials.gov/study/NCT04692818","title":"3D Multimodal Ultrasound Imaging for Breast Cancer","has_exemption":false,"start_date":"2021-11-10","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04707885","publication_url":"https://clinicaltrials.gov/study/NCT04707885","title":"Clinical Utility of Residual Hearing in the Cochlear Implant Ear","has_exemption":false,"start_date":"2021-11-10","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Ohio State University","sponsor_slug":"ohio-state-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04819841","publication_url":"https://clinicaltrials.gov/study/NCT04819841","title":"A Phase I/II Study of Nula-cel in Autologous CD34+ Hematopoietic Stem Cells to Convert HbS to HbA for Treating Severe Sickle Cell Disease","has_exemption":false,"start_date":"2021-11-15","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Kamau Therapeutics","sponsor_slug":"kamau-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04975555","publication_url":"https://clinicaltrials.gov/study/NCT04975555","title":"A Phase II Pilot Study to Evaluate the Role of Siltuximab in Treatment of Cytokine Release Syndrome (CRS) and Immune Effector Cell Associated Neurotoxicity (ICANS) Related to Chimeric Antigen Receptor T-Cell Therapy (CAR-T) in Hematological Malignancies","has_exemption":false,"start_date":"2021-11-15","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"University of Alabama at Birmingham","sponsor_slug":"university-of-alabama-at-birmingham","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05729542","publication_url":"https://clinicaltrials.gov/study/NCT05729542","title":"Randomized Controlled Trial Comparing Clinical Outcomes of Patients Treated Surgically With Suture Button Versus Fibulink Fixation for Acute Ankle Syndesmosis Injuries","has_exemption":false,"start_date":"2021-11-18","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"University of California, San Diego","sponsor_slug":"university-of-california-san-diego","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05205330","publication_url":"https://clinicaltrials.gov/study/NCT05205330","title":"An Open-label, Single-arm, Phase Ib/IIa Trial to Evaluate the Safety and Efficacy of the EP4 Receptor Antagonist Vorbipiprant (CR6086) in Combination With the PD-1 Inhibitor Balstilimab (AGEN2034), in Patients With Pretreated Mismatch-repair-proficient and Microsatellite Stable Metastatic Colorectal Cancer, and Other Metastatic GI Cancers.","has_exemption":false,"start_date":"2021-11-23","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Rottapharm Biotech","sponsor_slug":"rottapharm-biotech","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05173714","publication_url":"https://clinicaltrials.gov/study/NCT05173714","title":"Sit Less, Interact and Move More (SLIMM) 2 Study","has_exemption":false,"start_date":"2021-12-01","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Srinvasan Beddhu","sponsor_slug":"srinvasan-beddhu","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05196984","publication_url":"https://clinicaltrials.gov/study/NCT05196984","title":"Acute Exposure of Individuals With Down Syndrome to Gamma Frequency Stimulation","has_exemption":false,"start_date":"2021-12-06","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Massachusetts Institute of Technology","sponsor_slug":"massachusetts-institute-of-technology","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05000294","publication_url":"https://clinicaltrials.gov/study/NCT05000294","title":"Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Types","has_exemption":false,"start_date":"2021-12-07","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"University of Florida","sponsor_slug":"university-of-florida","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05241210","publication_url":"https://clinicaltrials.gov/study/NCT05241210","title":"Real-Time Feedback (RTFB) to Improve Colonoscopy","has_exemption":false,"start_date":"2021-12-13","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"University of Minnesota","sponsor_slug":"university-of-minnesota","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04019262","publication_url":"https://clinicaltrials.gov/study/NCT04019262","title":"Short Course Chemo-Radiation Therapy for Patients With Newly Diagnosed Glioblastoma: Comparison of Two Established Schedules","has_exemption":false,"start_date":"2021-12-14","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"John Flickinger","sponsor_slug":"john-flickinger","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04933149","publication_url":"https://clinicaltrials.gov/study/NCT04933149","title":"Ketamine Infusion for Treatment of Chronic Neuropathic Pain in Traumatic Brachial Plexus Injuries, a Prospective Randomized Control Study","has_exemption":false,"start_date":"2021-12-15","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05167721","publication_url":"https://clinicaltrials.gov/study/NCT05167721","title":"Randomized Double-Blind Placebo-Controlled Adaptive Design Trial Of Intrathecally Administered Autologous Mesenchymal Stem Cells In Multiple System Atrophy","has_exemption":false,"start_date":"2021-12-15","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04989946","publication_url":"https://clinicaltrials.gov/study/NCT04989946","title":"Phase I/II Trial of Androgen Deprivation, With or Without pTVG-AR, and With or Without T-Cell Checkpoint Blockade, in Patients With Newly Diagnosed, High-Risk Prostate Cancer","has_exemption":false,"start_date":"2021-12-16","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"University of Wisconsin, Madison","sponsor_slug":"university-of-wisconsin-madison","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05013255","publication_url":"https://clinicaltrials.gov/study/NCT05013255","title":"Pioglitazone Therapy Targeting Fatigue in Breast Cancer","has_exemption":false,"start_date":"2021-12-23","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"West Virginia University","sponsor_slug":"west-virginia-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04894734","publication_url":"https://clinicaltrials.gov/study/NCT04894734","title":"The Feasibility of Epidural Electrical Stimulation (EES) for Improving Pain and Rehabilitation Outcomes in Patients With Spinal Cord Injury (SCI)","has_exemption":false,"start_date":"2021-12-30","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Nandan Lad, M.D., Ph.D.","sponsor_slug":"nandan-lad-md-phd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04521699","publication_url":"https://clinicaltrials.gov/study/NCT04521699","title":"Examination of the Impact of CalmiGo's Stress Management Device on Vascular Health and Cardiovascular Disease Risk , and Markers of Mental Stress in Patients Following a Myocardial Infarction Participating in Clinically Indicated Cardiac Rehabilitation","has_exemption":false,"start_date":"2022-01-13","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05170919","publication_url":"https://clinicaltrials.gov/study/NCT05170919","title":"An Efficacy Study Comparing Olanzapine and Mirtazapine in the Improvement of Unintentional Weight Loss for Patients with Advanced Stage Cancer","has_exemption":false,"start_date":"2022-01-20","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Englewood Hospital and Medical Center","sponsor_slug":"englewood-hospital-and-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05210114","publication_url":"https://clinicaltrials.gov/study/NCT05210114","title":"Cutaneous Hydration Assessment in Sickle Cell Disease","has_exemption":false,"start_date":"2022-01-21","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Enrico Novelli","sponsor_slug":"enrico-novelli","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04870944","publication_url":"https://clinicaltrials.gov/study/NCT04870944","title":"A Phase 1/2 Trial of CBL0137 (NSC# 825802) in Patients With Relapsed or Refractory Solid Tumors Including CNS Tumors and Lymphoma","has_exemption":false,"start_date":"2022-01-28","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Children's Oncology Group","sponsor_slug":"childrens-oncology-group","status":"ongoing","is_pact":false,"days_late":null}]}